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This dissertation describes new peptide-based methods for assembling and controlling the 
morphologies, metrics, and properties of gold nanoparticle superstructures. The aim of this 
research is to develop the peptide-based method by modifying the peptide sequences and 
controlling the reaction conditions for the synthesis and assembly of gold nanoparticle 
superstructures to achieve reliable control over their morphology and metrics, and furthermore 
study their properties and applications. 
With this goal in mind, the C-terminus of a gold-binding peptide was modified with different 
numbers of hydrophobic phenylalanines to affect peptide assembly and ultimately nanoparticle 
assembly. The addition of hydrophobic phenylalanines to the C-terminus of peptide conjugates 
promoted fiber bundling which in turn lead to the formation of thick or intertwined 1-D 
nanoparticle superstructures. Furthermore, I prepared spherical gold nanoparticle superstructures 
with varied diameters (~40nm, ~75nm, and ~150nm) and visible to near-infrared optical 
properties by using a single peptide conjugate molecule yet varied reaction conditions. 
Theoretical simulation and experiment were coupled to further understand their optical 
properties. Finally, I studied and demonstrated the drug storage and release properties of hollow 
spherical gold nanoparticle superstructures; this was the first demonstrated application of this 
class of nanoparticle superstructure. 
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 1 
1.0  INTRODUCTION 
1.1 GOLD NANOPARTICLES AND THEIR OPTICAL PROPERTIES 
Nanostructures are materials that have at least one dimension within 1-100 nm. Materials 
confined to the nanometer size regime exhibit very different mechanical, electronic, magnetic, 
optical, and chemical properties compared to those of bulk materials.1 Recently, nanoparticles 
composed of metals, semiconductors, or metal oxides have attracted broad interest due to their 
unique properties and potential applications in various areas including electronic devices,2 bio-
imaging tools,3 drug delivery vehicles,4 biosensors,5 etc. 
As a class of noble metal nanoparticles, gold nanoparticles can be dated as far back as the 
5th century B.C. when the term “colloidal gold” was in existence, long before the development 
of modern gold chemistry.6 Due to their unique optical, electronic, and catalytic properties, gold 
nanoparticles are the subject of substantial research.6 One of the most interesting and powerful 
properties of gold nanostructures is their surface plasmon resonance (SPR).7 When gold 
nanoparticles are irradiated by light of a certain wavelength, the conduction electrons of gold 
nanoparticles begin to oscillate, creating a dipole, which gives the so-called “dipole SPR” of gold 
nanoparticles.7 Figure 1 illustrates this phenomenon for a spherical gold nanoparticle. The SPR 
can be observed using UV-Vis spectroscopy. The instrument detects both scattering and 
absorption, which together represents the ‘extinction’.  The SPR creates strong electric fields 
close to the surface of gold nanoparticles, which can be directly applied to surface-enhanced 
Raman scattering (SERS).8 
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Figure 1.  Surface plasmon resonance (SPR) is a critical property of gold nanostructures that results from 
the collective oscillation of delocalized electrons in response to an external electric field. (Adapted from ref.8). 
 
Gold nanoparticles exhibit unique size-, shape- and composition-dependent properties. 
For instance, compared with the yellow color of bulk gold, gold nanospheres of diameter ∼100 
nm or smaller appear crimson when suspended in water, and gold nanoparticles of diameter less 
than ∼3 nm are no longer “noble”, but show catalytic properties.6 The SPR of gold 
nanostructures depends on the size, shape, and morphology of the nanostructure, as well as the 
dielectric environment,7 which provide a good variety of routes to control SPR response. The 
SPR extinction of spherical gold nanoparticles red shifts as their diameters increase. 
Consequently, gold nanoparticle colloidal solutions have different colors depending on their size 
(Figure 2a-b).9 Non-spherical shaped gold nanoparticles such as rods, cubes, wires, belts, and 
tubes are found to possess properties dependent not only on the size but also shape.7 Compared 
with spherical gold nanoparticles, gold nanorods have two distinctive peaks in their UV-Vis 
spectrum, which correspond to the transverse and longitudinal SPR modes (Figure 2c-d).10-13 
Another way to control the SPR response and introduce more properties is by tuning the 
 3 
composition of gold nanoparticles, for example, preparing core-shell or alloyed structures. 
Tuning the shell thickness of core-shell structures or the ratio between the constituent 
compositions in alloy structures have a pronounced effect in their SPR response.14,15 For instance, 
gold nanoshells were synthesized and developed by Halas and co-workers in the late 1990’s. The 
SPR for these materials could be adjusted from visible to NIR region by tuning the ratio between 
the diameter of the whole particle and the thickness of gold nanoshell (Figure 2e).15   
 
 4 
 
 
Figure 2.  (a) Solutions of gold nanoparticles with different diameters and (b) UV-vis spectrum of gold 
nanoparticles with different diameters (Adapted from ref.9); (c) Transmission electron microscope (TEM) image of 
gold nanorods and (d) UV-vis spectrum of gold nanorods (Adapted from ref.10); (e) Graphical illustrations, and (f) 
synthetically tunable extinction spectra for gold nanoshells (Adapted from ref.14). 
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For biomedical applications, gold nanostructures that absorb strongly in the near-infrared 
(NIR) window (650–900 nm) attract the most interest, as light can penetrate deeply into tissue in 
this region due to the low absorption from blood and water.16 Changes in the size can lead to a 
shift of the SPR band, however, to achieve strong extinction in the NIR region it is necessary to 
fabricate new morphologies and structures with more tunable plasmonic properties.14 One of the 
general strategies utilized to shift the SPR into the NIR region is to carefully control the aspect 
ratio for solid structures or tune the shell thickness of hollow or core–shell structures.17 Three 
widely studied types of gold nanostructures with tunable vis-NIR absorbance have been prepared: 
gold nanorods (Figure 3a),13 gold nanoshells (Figure 2e),15 and gold nanocages (Figure 3b)18. 
Spectral red-shifts can be achieved by increasing aspect ratio, decreasing shell thickness, and 
increasing gold content percent, respectively.  
 
 
Figure 3.  Graphical illustrations, transmission electron micrographs, and synthetically tunable extinction 
spectra for (a) gold nanorods, (b) gold nanocages. The near infrared (NIR) tissue transmission window is depicted as 
a green box in each of the spectra (Adapted from ref.14). 
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1.2 GOLD NANOPARTICLE ASSEMBLIES AND THEIR PROPERTIES 
When nanoparticles are assembled together into superstructures, new collective properties 
emerge.19,20 These collective properties depend not only on the size, shape, and composition of 
the constituent particles (building blocks), but also on how the nanoparticles are assembled, 
including the morphology of the assembly, particle placement, and interparticle distances. These 
collective properties are a result of the coupling of the excitons,21,22 magnetic moments,23,24 and 
surface plasmons25-27 of individual nanoparticles.  
It is well-known that the intrinsic properties of individual nanoparticles are mainly 
dominated by their size, shape, and compositions. However, when gold nanoparticles are placed 
close to each other within an assembly, the interparticle coupling effect becomes increasingly 
prominent. Besides the intrinsic properties of nanoparticles (size, shape, composition, etc.), the 
collective properties will be also affected by how the nanoparticles are assembled. For example, 
by controlling the distance between gold nanoparticles, one can tune the color from pink to violet 
to blue, which manifests itself as a continuing red shift in the UV-Vis spectrum.28 Well-defined 
1-D, 2-D, and 3-D assemblies of gold nanoparticles prepared from finely-controlled nanoparticle 
building blocks present the opportunity to optimize the properties of materials and realize new or 
potentially useful collective properties, leading to extensive applications in many different areas, 
such as optics, sensor, catalysis, biomedicine, etc.29  
As an example of 1-D gold nanoparticle assemblies in optics, linear waveguides of 10 nm 
gold nanoparticles were prepared by Kuang et al by employing a DNA-origami-templated self-
assembly (Figure 4a-b).30 Using DNA origami as a template, they were able to precisely control 
both interparticle distances and spatial arrangement, leading to distinctive optical properties. A 
multi-scaffold, two-nanotube nanorail structure was used to improve the mechanical rigidity and 
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linearity of the waveguides. Their results demonstrated the use of DNA origami for the synthesis 
of relatively large and complex optical waveguides. 
In the meantime, tubular assemblies of gold nanoparticles were reported for their 
potential as catalyst for organic reactions. Huang et al used gold nanoparticles stabilized by an 
amphiphilic pillar[5]arene to construct composite microtubes in water without any external 
assistance (Figure 4c).31 These tubular assemblies of gold nanoparticles exhibited high stability 
at high temperature or in the presence of strong acid and base. More importantly, they were used 
to catalyze the borohydride reduction of p-nitroaniline to 1,4-diaminobenzene with a yield loss 
within 3% for 20 cycles.  
In the area of sensors, Halas et al applied a convenient approach to prepare highly-
ordered gold nanoparticle 2-D arrays with sub-10 nm interparticle gaps as SERS substrates 
(Figure 4d-e).32 These interparticle gaps lead to enhanced near-field and create the so-called 
“hot spots” within the periodic arrays which can be utilized for large SERS enhancements. As 
SERS substrates, these gold nanoparticle arrays exhibited very high SERS sensitivity, long-term 
stability, and consistent reproducibility.  
Assembling gold nanoparticles into hollow spherical superstructures is an effective way 
to achieve NIR extinction for biological applications. Duan et al fabricated biodegradable 
theranostic plasmonic vesicles of amphiphilic gold nanorods (Figure 4f-h).33 These vesicular 
assemblies of gold nanorods could be either degraded by enzymes or NIR photothermal heating. 
Coupled with Raman probes, these nanorod assemblies gave highly active SERS signals. 
Furthermore, the hollow features offered opportunities for carrying anti-cancer drugs to kill 
targeted cancer cells. Integrated with the photothermal effect of gold nanorods, these vesicular 
assemblies have potential applications as theranostic materials. By using a peptide-based method, 
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I have successfully prepared hollow spherical gold nanoparticle superstructures. In the third and 
fourth chapter of this thesis, these spherical gold nanoparticle superstructures with tunable Vis-
NIR extinction and their drug release properties will be discussed. 
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Figure 4. (a) The combined height atomic force microscope (AFM), darkfield, and magnified AFM scan of 
the characterized waveguides images of the waveguides and (b) the measured scattering spectra of the waveguides 
shown in the AFM inset (Adapted from ref.30); (c) Schematic illustration of the self-assembly process of water-
soluble gold nanoparticles into self-assembled composite microtubes (Adapted from ref.31); (d) Scanning electron 
microscope (SEM) images of gold nanoparticle arrays and (e) Empirical SERS enhancement factors obtained on the 
basis of different Raman modes under different laser excitations (Adapted from ref.32); (f) SEM images of gold 
nanorod vesicles, (g) release profiles of drug-loaded vesicles in PBS with enzyme (green line), pH 5.0 acetate buffer 
(blue line), and pH 7.4 PBS (black line) and (h) release profiles of drug-loaded vesicles without (purple line) and 
with laser at 1.0 W/cm2 (orange line) and 2.5 W/cm2 (green line) for 8 min irradiation (Adapted from ref.33). 
1.3 CHALLENGES IN NANOPARTOCLE ASSEMBLY 
Although nanoscientists have accomplished a lot in terms of fabrication and property control of 
nanoparticle assemblies, there is still room for improvement and exploration. First, I still need to 
explore more methods for the fabrication of nanoparticle assemblies with well-defined and more 
complex morphologies. Second, control over the metrics of nanoparticle assemblies, such as the 
diameter of individual nanoparticles and the entire structure and interparticle distances remains 
crucial for tuning the properties. Third, more studies on nanoparticle assemblies with various and 
multiple compositions should be explored. By addressing these challenges, researchers would be 
able to understand and better control the properties of nanoparticle assemblies, and ultimately 
realize their potential applications. My research is mainly focused on developing new methods 
for controlling the morphology and metrics of gold nanoparticle superstructures and studying 
their properties and applications. 
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1.4 METHODS FOR ASSEMBLING NANOPARTICLES 
Inorganic nanomaterials are typically prepared by using either a “top-down” approach or a 
“bottom-up” approach.34 ‘Top down’ approaches offer fine control over the size, shape, and 
morphology and allow for control over the local order of the nanoparticles; however, they are 
relatively time-consuming and costly, and generally cannot be used for the construction of 
complex 3-D structures. In contrast, like most assembly processes in nature, the “bottom-up” 
approaches are simple and versatile, where building blocks are linked together through self-
assembly. These building blocks can be designed precisely to facilitate the self-assembly of 
nanostructures with tunable features. Moreover, the “bottom-up” approaches can be used for 
constructing 1-D, 2-D, and very complex 3-D nanostructures.35  
One of the most common “bottom-up” approaches is the template-based method, in 
which pre-assembled templates can direct the subsequent assembly of nanoparticles. Most 
template-based approaches require multiple synthetic steps, involving: 1) template synthesis and 
assembly, 2) nanoparticles preparation, and finally 3) using the template to direct the assembly of 
nanoparticles. Various templates can be utilized, such as carbon nanotubes,36,37 polymers,38 
viruses39 or biomolecules40.  For example, Matsui et al have fabricated gold nanoparticle 
superstructures by using histidine-rich peptide nanotubes as templates.  They coated these 
templates with monodisperse gold nanoparticles  (Figure 5).40 
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Figure 5. Fabrication of gold nanoparticle superstructure by using histidine-rich peptide nanotubes as 
templates (Adapted from ref.40). 
 
Another method is to assemble nanoparticles at liquid-liquid, liquid-air, or liquid-solid 
interfaces using Langmuir-Blodgett techniques,41-43 sedimentation, or evaporation44-46. These 
methods are very convenient and can be used for preparing large-scale structures. Nanoparticle 
assemblies with various compositions can be made using such methods. These methods can 
provide well-ordered assemblies. For instance, Figure 6 shows different types of binary 
superlattices assembled from nanoparticles with different compositions, induced by solvent 
evaporation.44  
 
 13 
 
 
Figure 6. TEM images of the binary superlattices self-assembled from different nanoparticles and modeled 
unit cells of the corresponding three-dimensional structures. The superlattices are assembled from (a) 13.4 nm Fe2O3 
and 5.0 nm Au, (b) 7.6 nm PbSe and 5.0 nm Au, and (c) 6.2 nm PbSe and 3.0 nm Pd (Adapted from ref.44). 
 
In addition, assembly of nanoparticles can be realized under external forces, such as 
electric fields, magnetic fields, or light.  These methods are classified as ‘assisted-assembly’.47 
Figure 7 shows chain-like assemblies of iron oxide nanoparticles aligned under a magnetic 
field.48   
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Figure 7. TEM images of nanocrystals deposited (a) without and (b) with a magnetic field form isotropic 
clusters during the evaporation process (Adapted from ref.48). 
 
Many solution-based methods for assembling nanoparticles also exist and some yield 
well-defined nanoparticle assemblies. These assemblies are formed using dipole-dipole 
interactions, electrostatic interactions, steric forces, covalent or hydrogen bonding, depletion 
forces, hydrophobic-hydrophilic interactions, etc.47,49 For instance, as shown in Figure 8, Nie et 
al prepared end-by-end or side-by-side assemblies  of  gold  nanorods driven  by  the attraction  
between  the  distinct ligands attached to the long and short facets of the nanorod assemblies in 
different solvents.50 
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Figure 8. SEM images of self-assembly of gold nanorods end-terminated at both ends with polystyrene 
molecules in selective solvents in chains (left) and side-to-side aggregated bundles (right). Scale bar is 100 nm 
(Adapted from ref.50). 
1.5 PEPTIDE-BASED METHOD FOR THE SYNTHESIS AND ASSEMBLY OF 
GOLD NANOPARTICLES 
The control over the collective properties of nanoparticle assemblies is crucial for realizing 
applications, and requires precise control over the morphology, metrics and composition of 
nanoparticle superstructures. However, with current methodologies there still exist limitations in 
achieving control of nanoparticle assemblies. For instance, template-based methods yield 
superstructures with well-defined shapes, but often times lack control over the local order of 
nanoparticles. Moreover, self-assembly of nanoparticles at interfaces does not allow for the 
synthesis of complex multi-dimensional structures. Lastly, assisted-assembly of nanoparticles 
requires external driving forces and cannot target complex structures either. Therefore, 
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development of facile and efficient methodologies for rational design and fabrication of well-
organized nanoparticle superstructures still remains challenging. Our group has developed a new 
peptide-based method that involves the simultaneous synthesis, growth, and assembly of nano-
architectures.  
Peptides exhibit unique properties that make them ideal for directing the growth and self-
assembly of inorganic nanoparticles.  The intrinsic structures of peptides, including their primary 
sequences and lengths, endow them with specific recognition capabilities and unique self-
assembly capabilities. 
Recognition Capabilities of Peptides. Through observations in nature or applications of 
phage display technology,51 many peptides are found to have highly specific recognition 
capabilities, which allow them to selectively bind to specific inorganic surfaces. Peptides having 
high binding affinities to gold,40,52,53 silver, 54 zinc sulfide,55 and other inorganic materials56-61 
have already been found. In addition, computational simulation and experiment have been 
employed to study and assess their binding ability.62-65 
Self-Assembly Capabilities of Peptides. In addition to their unique recognition 
properties, peptides also exhibit interesting self-assembly capabilities. Intrinsic structures readily 
drive peptides to fold into one or more spatial conformations such as -helix and -sheet 
conformations. A number of non-covalent interactions, such as hydrogen bonding, ionic 
interactions, van der Waals forces, hydrophobic packing (aliphatic residues) and –  stacking 
(aromatic residues) between residues play an instrumental role in both peptide self-assembly and 
stabilization of the secondary structures. Various molecules can be designed and coupled to 
peptides to affect self-assembly and add functionality. Such modified peptides are often called 
“peptide conjugates”.34 For instance, peptide amphiphiles represent a simple category of peptide 
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conjugate molecules designed to self-assemble. These peptide amphiphiles possess similar 
structure and chemical properties with lipids and surfactants. Typically, they are composed of a 
hydrophobic alkyl tail and hydrophilic peptide head which can self-assemble in aqueous solution 
to form well-defined nanostructures such as peptide bilayers, nanotubes, nanorods, nanoribbons, 
fibers, vesicles, and micelles (Figure 9).66-69 When these molecules assemble in water, they 
generally form highly ordered structures with hydrophobic alkyl tails in the core and hydrophilic 
peptides in the exterior.70,71 
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Figure 9. (a) Negatively stained TEM image and (b) SEM image of nanotubes formed by diphenylalanine 
peptide (Adapted from ref.66); (c) Chemical structure and schematic showing the self-assembly of peptide 
amphiphile molecules into a cylindrical micelle, and (d) TEM image of the fibers formed by peptide amphiphile 
molecules (Adapted from ref.67); (e) Schematic drawing showing proposed self-assembly of K60L20 into vesicle and 
(f) negatively stained TEM image of K60L20 vesicles (the scale bar is 350 nm) (Adapted from ref.69). 
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The Rosi Group has developed a new peptide-based method, which aims to address the 
challenges of nanoparticle assembly by promoting the simultaneous synthesis, growth and 
assembly of nanoparticles. The group began with attaching a hydrophobic aliphatic tail (C12 = 
C12H23O) to a specific gold-binding peptide (PEPAu =AYSSGAPPMPPF),
59 and developed a 
one-pot reaction to prepare 1-D double-helical gold nanoparticle superstructures with precise 
local order (Figure 10).  It is hypothesized that the self-assembly of the peptide and the growth 
of gold nanoparticles are coupled into a simultaneous process.53,72 After this initial result, the 
group demonstrated the careful control over the metrics of the double helical gold nanoparticle 
superstructures (e.g. the size and density of the nanoparticles within the assembly, and 
interhelical distances) by tuning the synthetic conditions.72 In a later report, the group prepared 
double-helical gold nanoparticle superstructures with controllable handedness and structural 
metrics, and revealed their tailorable chirooptical properties by coupling theoretical simulation 
and experimental measurement.73 These studies illustrate the utility of our peptide-based method 
for designing and preparing complex plasmonic materials with tailorable structural metrics and 
chirooptical properties. 
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Figure 10. (a) and (b) TEM images of left-handed gold nanoparticle double helices; (c) Tomographic 3-D 
reconstruction image of left-handed gold nanoparticle double helices; (d) Schematic view of the formation of left-
handed gold nanoparticle double helices (Adapted from ref. 53). 
 
In addition to the 1-D gold nanoparticle superstructures, hollow spherical gold 
nanoparticle superstructures were also prepared in a similar manner. In 2010, the group reported 
that C6-AA-PEPAu conjugates (C6 = C6H11O, A = alanine) could direct the synthesis and 
assembly of hollow spherical gold nanoparticle superstructures (Figure 11a).74 These structures 
consisted of a monolayer shell of ~8 nm gold nanoparticles around a vesicular self-assembled 
peptide conjugate core. After this initial report, the group demonstrated that BP-Ax-PEPAu 
(C12H9CO–Ax–AYSSGAPPMPPF; x = 2 or 3; BP = biphenyl) could also direct the formation of 
hollow spherical gold nanoparticle superstructures with controllable diameters (large, >100 nm 
or small, ~30 nm) by tuning the number of additional alanine residues at the N-terminus (2 or 3) 
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(Figure 11b).75 Unique features of these spherical structures include their small diameter and 
hollow interior, which suggest their potential application in biomedicine. 
 
 
 
Figure 11. (a) Synthetic scheme and TEM images for spherical gold nanoparticle superstructures using C6-
AA-PEPAu (Adapted from ref.74); (b) Synthetic scheme and TEM images for spherical gold nanoparticle 
superstructures using C6-AA-PEPAu (Adapted from ref.75). 
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1.6 RESEARCH OBJECTIVES 
The Rosi Group have already demonstrated that the new peptide-based method can be used to 
construct gold nanoparticle superstructures with various morphologies and controlled metrics. 
However, several research directions remain unexplored. For example, all the gold nanoparticle 
superstructures previously reported were prepared by using peptides modified at their N-
terminus. Modification of the peptide at the C-terminus could have a dramatic effect on the 
assembling behaviour of the peptide conjugate molecules and in turn lead to the assembly of 
nanoparticle superstructures with new morphologies. In addition, the hollow spherical gold 
nanoparticle superstructures previously synthesized are not suitable for studying their optical 
properties due to the low yield. Furthermore, using this class of spherical assemblies for real 
applications is an attractive research direction. Therefore, the objectives of this dissertation are as 
follows: 1) preparation of peptide conjugate molecules with C-terminal modifications and using 
them for the synthesis of gold nanoparticle superstructures; 2) preparing high quality spherical 
gold nanoparticle superstructures, systematically adjusting their structural metrics, and exploring 
their optical properties; and 3) using spherical gold nanoparticle superstructures as cargo carriers 
and studying their drug release properties. 
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2.0  PEPTIDE CONJUGATES FOR DIRECTING THE MORPHOLOGY 
AND ASSEMBLY OF NANOPARTICLE SUPERSTRUCTURES 
A portion of this work, written in collaboration with Chengyi Song, H. Christopher Fry, and 
Nathaniel L. Rosi*, was published in Chem. Eur. J. 2014, 20, 941. 
2.1 INTRODUCTION 
Inorganic nanoparticles are important structural and functional building blocks for the assembly 
of new advanced materials.6,12,34,47,76-82 Any given material may have a hierarchy of structural 
and functional domains, including, for example, nanoparticles, nanoparticle superstructures, and 
finally assemblies of nanoparticle superstructures. Controlling each level of this hierarchy is 
essential for controlling material properties and, ultimately, application. Numerous methods exist 
for preparing discrete nanoparticles of various size, shape, and composition,6,12,76-78 and the 
number of viable methods for carefully assembling nanoparticles into nanoparticle 
superstructures is rapidly growing.34,47,79-82 Ideally, nanoparticle assembly methods should permit 
control over each level of a material’s structural hierarchy: i) the size, shape, and composition of 
the nanoparticle building blocks; ii) the metrics, shape, and topology of the nanoparticle 
superstructure; and iii) the co-assembly of the nanoparticle superstructures into larger scale 
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structures. In this chapter, I present assembly methods that address i)-iii) in the context of 
constructing and assembling 1-D gold nanoparticle superstructures. 
The Rosi Group has developed synthetic methods that utilize peptide conjugate molecules 
to direct the simultaneous synthesis and assembly of inorganic nanoparticles.53,72-75,83,84 The 
peptide conjugates consist of a peptide having a particular sequence of amino acids for binding 
to a specific inorganic surface34,51 and a particular organic moiety attached to the peptide N-
terminus that influences peptide assembly. Such peptide conjugates can be used to prepare a 
diverse collection of complex nanoparticle assemblies having well-defined structures with 
tailorable shapes, metrics, and properties.53,72-75,83,84  One can make numerous modifications to 
the peptide conjugate molecule (Scheme 1) that may affect its assembly. Existing modifications 
include: i) incorporating structure-directing moieties, such as peptide sequences that induce α-
helix85 or β-sheet86 conformations; ii) attaching stimuli-responsive groups, such as those 
responsive to oxidation or reduction,87 metal ions,88-90 pH,91 light,92 and temperature93, to induce 
structure assembly. For example, Pires et al. reported a collagen triple helical peptide modified 
with a His2 moiety at the C-terminus and a nitrilotriacetic acid unit at the N-terminus. This 
peptide conjugate can rapidly and reversibly assemble with the addition of metal ions.94 However, 
almost all of these modifications aim to influence the intermolecular interaction; few examples 
exist for controlling the interaction between preformed assemblies and lead to the subsequent co-
assembly of these assemblies into larger-scale structures. Studies that explore how modifications 
to the peptide backbone affect the morphology of nanoparticle superstructures are not common, 
with the exception of prior work from the Rosi Group (vide infra). 
Much of the previous work in the Rosi Group has focused on modifying the N-terminus 
with various aliphatic carbon chains or π-conjugated molecules, such as C12 carbon chain 
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(C12H23O-) and biphenyl group (R in Scheme 1).
53,74,75,83,84 One can also modify the peptide 
sequence, provided that these modifications do not alter the peptide’s inorganic recognition 
sequence and therefore its inorganic binding capabilities. Along these lines, prior group members 
have introduced alanine residues to the N-terminus (Xm in Scheme 1) of a gold-binding peptide 
(PEPAu = AYSSGAPPMPPF)
52 and shown how these additional amino acids influence peptide 
conjugate assembly and ultimately nanoparticle superstructure assembly.74,75 When such 
conjugates are allowed to assemble in aqueous conditions, the hydrophobic organic molecule and 
the amino acids at the N-terminus are expected to locate in the core of the peptide assembly 
while the bulk of the peptide and its C-terminus are expected to locate on the surface of the 
assembly, exposed to the aqueous buffer solution.67,95-98 Based on this assembly paradigm, I 
predict that modifications to the C-terminus (Yn in Scheme 1) should significantly affect 
conjugate assembly and possibly lead to new nanoparticle superstructures.  
 
 
 
Scheme 1. Illustration of a peptide conjugate detailing the different potential regions for modification: R = 
organic tails; Xm and Yn = additional amino acids; PEPAu = AYSSGAPPMPPF. 
 
Previously, the Rosi group demonstrated that C12-PEPAu (PEPAu having a C12 chain 
attached to its N-terminus; C12 = C12H23O) assembles into 1-D twisted fibers and directs the 
synthesis and assembly of left-handed gold nanoparticle double-helical superstructures.53 These 
helical superstructures exhibit plasmonic circular dichroism properties,73 which could ultimately 
be useful for the preparation of chiral metamaterials,99,100 provided that individual double helices 
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could be aggregated together into an extended array. It is well-established that hydrophobic F 
residues can impact peptide assembly in aqueous conditions,101,102 and that F2 alone, for example, 
assembles into nanotubular structures.66 My hypothesis in this work is that the addition of extra 
phenylalanine (F) residues to the C-terminus of C12-PEPAu could promote inter-fibril interactions 
in buffer that would lead to the formation of fiber bundles, which could in turn serve to direct the 
formation of thick linear nanoparticle superstructures or possibly even bundles of double-helical 
superstructures. Thus, the C-terminus might potentially be used as a handle for controlling the 
co-assembly of 1-D nanoparticle superstructures into larger scale structures. 
2.2 RESULTS AND DISCUSSION 
To explore this hypothesis, I designed the following series of peptide conjugate molecules: C12-
AYSSGAPPMPP (1), C12-AYSSGAPPMPPF (2),
53 C12-AYSSGAPPMPPFF (3), and C12-
AYSSGAPPMPPFFF (4). I first studied the assembly of these peptide conjugates in 0.1 M 
HEPES buffer (pH= 7.3 ± 0.1; HEPES = 4-(2-hydroxyethyl)-piperazineethanesulfonic acid). I 
dissolved samples of 1-4 in 0.1 M HEPES to yield 150 µM peptide conjugate solutions, which 
were allowed to sit at room temperature for various specific time periods (30 min, 1 day, 3 days, 
and 7 days). After these time periods, I spotted transmission electron microscopy (TEM) grids 
with samples from each solution, applied a phosphotungstic acid stain, and then imaged each 
sample via TEM to monitor the progress of assembly (Figure 12). Several general conclusions 
can be drawn from the microscopy data. First, after a short incubation period (30 min), no 
assembly is observed for 1, while 2 and 3 both assemble into spherical structures (diameter of 2 
= 21.3 ± 3.4 nm, based on 100 counts; diameter of 3 = 21.0 ± 3.8 nm, based on 100 counts), and 
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4 assembles into 1-D fibers (width = 6.5 ± 0.8 nm, based on 100 counts) (see Figure 13 for 
distribution diagrams). With increasing time, 1-4 all form fibers. For each conjugate, I observed 
an increasing number of fibers with increased incubation time, and also with increasing number 
of C-terminal F residues. Finally, I observed fiber bundling for both 2 and 3 after longer 
incubation times in HEPES buffer. Significant bundling for 3 was first observed after 1 day, and 
many thick bundles (width = 35.7 ± 12.4 nm) were observed after 1 week, as observed by both 
TEM (Figure 12) and tapping-mode atomic force microscopy (AFM) studies (Figure 14). The 
AFM data reveal fiber bundles having a height of ~20 nm, which indicates that these bundles are 
intertwined fibers rather than thick flat sheets of individual fibers. 2 required a longer incubation 
time to form bundles: significant fiber bundling was only observed after 3 days and after 1 week 
the bundling was not nearly as significant as 3. 4, which contain 3 terminal F residues, forms 
fibers most rapidly, and some of these fibers bundle together; however, fewer and thinner fiber 
bundles were observed for 4 than 3. Since 4 rapidly assembles into fibers, the fibers may 
precipitate from solution before having sufficient time to interact with each other during 
assembly to allow formation of large quantities of fiber bundles.   
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Figure 12. TEM images of soft assemblies prepared using peptide conjugates 1, 2, 3, or 4 in HEPES buffer 
at different time points (0.5 h, 1 d, 3 d, and 7 d). Arrows indicate points where individual or thin fibers merge to 
form thick fiber bundles. 
 29 
 
 
Figure 13. Diameter (spheres) or width (fibers or fiber bundles) distribution of all soft assemblies. (a) 
Diameter distribution of small spherical assemblies of 2: 21.3 ± 3.4 nm, based on 100 counts; (b) Diameter 
distribution of small spherical assemblies of 3: 21.0 ± 3.8 nm, based on 100 counts; (c) Width distribution of fibers 
formed using 1, 6.6 ± 0.8 nm, based on 100 counts; (d) Width distribution of fibers formed using 2, 6.7 ± 0.9 nm, 
based on 100 counts; (e) Width distribution of fibers formed using 3, 6.8 ± 0.8 nm, based on 100 counts; (f) Width 
distribution of fibers formed using 4, 6.5 ± 0.8 nm, based on 100 counts; (g) Width distribution of thick bundles 
using 3, 35.7 ± 12.4 nm, based on 100 counts. 
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Figure 14. Tapping-mode AFM image for fibers formed using peptide conjugate 3 (a, b are height images 
and c is the cross-section analysis). The AFM data reveal fiber bundles having a height of ~20 nm, which indicates 
that these bundles are intertwined fibers rather than thick flat sheets of individual fibers. 
 
The peptide conjugate assembly studies detailed above were performed in the absence of 
gold salt, an integral component of our nanoparticle superstructure syntheses.53,72-75,83 From 
previous studies, it is known that Au3+ (as well as other multivalent cations, such as Ca2+) can 
significantly accelerate and affect peptide conjugate assembly.53,89,90,103 Once gold salts are 
added to solutions of peptide conjugates in HEPES, however, fiber growth rapidly occurs and 
gold nanoparticles form and assemble along with the peptide conjugates into gold nanoparticle 
superstructures, because HEPES can reduce Au3+ to Au0.52,104 The gold nanoparticle 
superstructures can obscure observation of conjugate assembly. Therefore, in order to study 
conjugate assembly in the presence of metal cations, I added 1.5 µL of 0.1 M calcium chloride to 
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150 µM solutions of 1-4 in 125 µL 0.1 M HEPES (Figure 15). After incubating for 30 min at 
room temperature with added Ca2+, 1-4 each formed fibers. The degree of fiber formation 
increased with increasing number of C-terminal F residues and, again, some bundling was 
observed for 2 and 3, with 3 exhibiting much more significant bundling than 2. These results 
mirror what was observed after 7 day incubation without Ca2+, which suggests that increasing the 
ionic strength by adding Ca2+ accelerates the assembly process. I anticipated that assembly of 1-4 
in the presence of Au3+ would be similar to their assembly in the presence of Ca2+.  
 
 
 
Figure 15. Negative Stained TEM images of peptide conjugates 1 (a), 2 (b), 3 (c), or 4 (d) incubating in 
HEPES buffer for 30 min in the presence of Ca2+. 
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Having established that the addition of C-terminal F residues significantly affects fiber 
assembly and bundling, I next proceeded to explore the impact of these modifications on 
nanoparticle superstructure formation in the presence of gold salt. For these studies, I followed 
the group’s established synthetic protocol.53 1 µL of a chloroauric acid solution (0.1 M HAuCl4 
in 1.0 M TEAA; TEAA = triethylammonium acetate) was added to a solution of peptide 
conjugate (1-4) in 0.1 M HEPES buffer. After incubating these solutions for 1 day at room 
temperature, the reaction products were imaged using TEM (Figure 16-20). 1 yielded aggregates 
of 1-D gold nanoparticle superstructures (Figure 16a and Figure 17, width: 24.1 ± 4.1 nm, 
based on 100 counts; nanoparticle diameter: 8.1 ± 1.3 nm, based on 100 counts), while 2 yielded 
well-defined gold nanoparticle double helices, as previously reported (Figure 16b and Figure 18, 
width: 20.1 ± 1.8 nm, based on 100 counts; nanoparticle diameter: 7.3 ± 1.4 nm, based on 100 
counts). 3 yielded thick, branched 1-D nanoparticle superstructures (Figure 16c and Figure 19, 
width: 61.4 ± 15.7 nm, based on 100 counts; nanoparticle diameter: 6.3 ± 1.2 nm, based on 100 
counts). 4 resulted in thin intertwined 1-D nanoparticle superstructures (Figure 16d and Figure 
20, width: 20.5 ± 4.9 nm, based on 100 counts; nanoparticle diameter: 6.0 ± 1.1, based on 100 
counts). These results are illustrated and summarized in Scheme 2. 
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Figure 16. Zoomed-in TEM images of nanoparticle superstructures formed using peptide conjugates 1 (a), 
2 (b), 3 (c), and 4 (d). Red arrows indicate the regions of the structure that appear to exhibit a helical arrangement of 
the nanoparticles. 
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Figure 17. (a-b) TEM images of aggregates of 1-D gold nanoparticle superstructures formed using 1; (c) 
Width distribution of superstructures: 24.1 ± 4.1 nm, based on 100 counts; (d) Diameter distribution of gold 
nanoparticle within the superstructures: 8.1 ± 1.3 nm, based on 100 counts. 
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Figure 18. (a-c) TEM images of gold nanoparticle double helices formed using 2; (d) Width distribution of 
gold nanoparticle double helices: 20.1 ± 1.8 nm, based on 100 counts; (e) Diameter distribution of gold 
nanoparticles within the superstructures: 7.3 ± 1.4 nm, based on 100 counts. 
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Figure 19. (a-c) TEM images of thick, branched 1-D nanoparticle superstructures formed using 3; (d) 
Width distribution of superstructures: 61.4 ± 15.7 nm, based on 100 counts; (e) Diameter distribution of gold 
nanoparticles within the superstructures: 6.3 ± 1.2 nm, based on 100 counts. 
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Figure 20. (a-c) TEM images of thin, intertwined 1-D nanoparticle superstructures formed using 4; (d) 
Width distribution of superstructures: 20.5 ± 4.9 nm, based on 100 counts; (e) Diameter distribution of gold 
nanoparticle within the superstructures: 6.0 ± 1.1 nm, based on 100 counts. Red arrows indicate the regions of the 
structure that appear to exhibit a helical arrangement of the nanoparticles. 
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Scheme 2. The number of Fx residues (x= 0-3) at the C-terminus of C12-AYSSGAPPMPPFx determines the 
structure of 1-D gold nanoparticle superstructures. x=0: aggregated 1-D structures; x=1: double helices; x=2: thick, 
branched 1-D structures; x=3: thin, intertwined structures. 
 
The results from these studies are generally consistent with our peptide conjugate 
assembly studies. Superstructures formed using 1 are linear, yet very irregular (Figure 17). Here, 
the terminal F residue of PEPAu has been deleted; this may negatively affect the formation of 
discrete nanoparticles and lead to irregular or aggregated nanoparticles. In fact, previous studies 
have demonstrated that the terminal F residue of PEPAu is important for binding to the Au 
surface.65,105 3 predominantly forms thick bundles of fibers, which leads to the formation of 
thicker 1-D nanoparticle assemblies (Figure 19). In this case, I collected images of 
superstructure formation after 50 minutes of reaction (Figure 21). It is clear that multiple 
individual fibers bundle together to form thick fibers, and nanoparticle growth is observed on 
these thick bundles. At this stage, it is unclear why the nanoparticles only decorate the fiber 
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bundles rather than individual fibers; studies are currently underway that investigate the 
mechanism of superstructure formation using 3, which may provide insight into this observation.  
 
 
 
Figure 21. Negatively-stained TEM images of nanoparticle superstructures formed using peptide conjugate 
3 after 50 minutes of reaction. These images reveal that multiple fibrils bundle together, to form thick fiber bundles. 
The nanoparticle superstructures form upon these thick bundles. 
 
I observed some important similarities between the nanoparticle superstructure products 
of 2 and 4 (Figure 18 and 20). Consistent with previous studies,53,72,73 2 predominantly 
assembles into non-aggregated fibers, which lead ultimately to the formation of isolated double-
helical nanoparticle assemblies as the major product and some bundled and intertwined double 
helices. 4 forms a mixture of fibers and fiber bundles, which leads to the formation of some 
isolated yet a majority of intertwined 1-D nanoparticle superstructures. The widths of these thin 
nanoparticle superstructures (2: 20.1 ± 1.8 nm; and 4: 20.5 ± 4.9 nm) are consistent with having 
a single fiber (2: 6.7 ± 0.9 nm; and 4: 6.5 ± 0.8 nm) decorated with nanoparticles (2: 7.3 ± 1.4 nm; 
and 4: 6.0 ± 1.1 nm). The nanoparticle arrangement in the superstructures formed with 4 is 
difficult to discern, although some regions of the structure appear to exhibit a helical 
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arrangement of the nanoparticles (Red arrow in Figure 20). Superstructures from 4 assemble 
together to form larger scale structures with diameters ranging from ~20 nm to ~60 nm (Figure 
20). These data indicate that the addition of F residues (in the case of 4) provides a way to 
assemble helical nanoparticle assemblies into larger scale structures. 
To investigate whether C-terminal F residues are important for fiber formation and fiber 
bundling, I studied the assembly of C12-PEPAu-E (5; C12-AYSSGAPPMPPFE). E, glutamic acid, 
is hydrophilic. 150 μM solutions of 5 in 0.1 M HEPES buffer were allowed to stand for 1 week. 
Negatively-stained TEM images of the assembly product revealed only spherical assemblies 
(Figure 22). In the presence of Ca2+, only spherical assembly was observed after 30 min 
incubation. These data suggest that C-terminal hydrophobicity may be important for directing 
fiber formation and bundling. 
 
 
 
Figure 22. Negatively-stained TEM images of soft-assemblies prepared using peptide conjugate 5, after 
various incubation periods. 
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2.3 CONCLUSION 
In this study I investigated the impact that modifications to the C-terminus of C12-PEPAu have on 
the soft assembly of peptide conjugates and the structure and assembly of 1-D nanoparticle 
superstructures. I discovered that the addition of hydrophobic F residues can lead to fiber 
bundling which in turn leads to the formation of thick or intertwined 1-D nanoparticle 
superstructures. Compared with previous studies, in which modifications were made at the N-
terminus to affect the intermolecular interaction and in turn lead to the formation of diverse 
nanoparticle assemblies, modifying the C-terminus of peptide conjugates not only influence the 
intermolecular interaction but also promote the interaction between their superstructures. These 
results indicate that C-terminal modifications to peptide conjugates represent another category of 
synthetically-addressable features that can be carefully tuned to impact both the structure of 
nanoparticle superstructures and the co-assembly of these structures. Finally, these studies, when 
grouped with previous studies on these systems, demonstrate that peptide conjugates are a highly 
tailorable class of molecules whose structures and compositions can be carefully programmed to 
direct the synthesis and assembly of a diverse array of complex hierarchical nanoparticle-based 
structures. 
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2.4 EXPERIMENTAL SECTION 
2.4.1 Materials and methods 
All solvents and chemicals were obtained from commercial sources and used without further 
purification. 0.1 M HEPES Buffer (HEPES = 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid) was made by directly diluting 1.0 M HEPES buffer (pH = 7.3 ± 0.1; Fisher Scientific) with 
water (NANOpure, Barnstead DiamondTM System.; 18.2 MΩ). Peptides with sequences of 
AYSSGAPPMPP, AYSSGAPPMPPF, AYSSGAPPMPPFF, and AYSSGAPPMPPFFF were 
synthesized and purified by New England Peptide with final purity of 99%. AYSSGAPPMPPFE 
was prepared by Argonne National Laboratory with final purity of 99 %. Reverse-phase high-
pressure liquid chromatography (HPLC) was performed at ambient temperature with an Agilent 
1200 liquid chromatographic system equipped with diode array and multiple wavelength 
detectors using a Grace Vydac protein C4 column (214TP1010, 1.0 cm × 25 cm). Matrix-assisted 
laser desorption ionization time-of-flight (MALDI-TOF) mass spectra were obtained on an 
Applied Biosystem Voyager System 6174 MALDI-TOF mass spectrometer using α-cyano-4-
hydroxy cinnamic acid (CHCA) as the matrix. Transmission electron microscopy (TEM) 
samples were prepared by pipetting one drop of solution onto a 3-mm-diameter copper grid 
coated with carbon film; 2% aqueous phosphotungstic acid was used for negative staining. TEM 
was conducted on either a JEOL 200CX instrument operated at 200 kV and equipped with a 
Gatan CCD image system or FEI Morgagni TEM operated at 80kV and equipped with an AMT 
side mount CCD camera system. Samples for atomic force microscopy (AFM) were prepared on 
freshly peeled MICA substrates. Tapping-mode AFM was performed on a Veeco Dimension V 
SPM. 
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2.4.2 Preparation of N-hydroxyl-succinimide ester and peptide conjugates 
N-hydroxyl-succinimide ester. Dodecanoic acid (696 mg, 6 mmol) and N-hydroxysuccinimide 
(725 mg, 6.3 mmol) were dissolved in 30 mL dry ethyl acetate under an argon atmosphere. After 
addition of dicyclohexyl carbodiimide (DCC) (1341 mg, 6.5 mmol) at 0 ºC, the solution was 
stirred overnight at room temperature. The reaction mixture was processed by removing the 
precipitate via filtration. The solvent was removed under reduced pressure and the crystalline 
residue recrystallized from isopropanol (iPrOH) to yield the N-hydroxyl-succinimide ester (211 
mg, 1 mmol, 17%). 
Peptide Conjugates. Peptide conjugates (1-5) were synthesized and purified using established 
methods.53 Briefly, for 1, AYSSGAPPMPP (1.20 mg, 8.80 ×10-7 mol) was dissolved in 60 μL 
DMF. After the addition of dodecanoic N-hydroxyl-succinimide ester (0.6 mg, 2.81×10-6 mol) in 
60 μL DMF and 1 μL Et3N under stirring, the solution was stirred at room temperature for 16 
hours. Pure peptide conjugate 1 was obtained by conducting reversed-phase HPLC eluting with a 
linear gradient of 0.05% formic acid in CH3CN and 0.1% formic acid in water (5/95 to 95/5 over 
30 min). The molecular weight for each peptide conjugate was confirmed by MALDI-TOF mass 
spectrometry. Concentration of the peptide was determined spectrophotometrically in 
water/acetonitrile (1:1) using the molar extinction coefficient of tyrosine (1280 M-1cm-1) at 280 
nm. 
Note: Peptide conjugates 2, 3, 4 and 5 were prepared, purified, and characterized in a similar 
fashion. 
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2.4.3 Peptide conjugate soft assembly 
Lyophilized peptide conjugate 1 (~ 3.74 × 10-8 mol) was completely dissolved in 250 μL of 0.1 
M HEPES buffer in a plastic vial. The above solution was incubated at room temperature and 
negatively stained TEM samples were prepared at different time points (0.5 h, 1 d, 3 d, and 7 d). 
The vial was capped to minimize evaporation of solvent. 
Note: Soft assembly of peptide conjugates 2, 3, 4 and 5 were studied in a similar fashion. 
2.4.4 Preparation of gold nanoparticle superstructures 
A gold ion precursor solution was prepared: 0.1 M chloroauric acid (HAuCl4) in 1.0 M 
triethylammonium acetate (TEAA; pH = 7.0) buffer was incubated for 10 minutes at room 
temperature. Thereafter, this mixture was centrifuged (10 min., 5K rpm). Lyophilized peptide 
conjugate 1 (~ 3.74 ×10-8 mol) was completely dissolved in 250 μL of 0.1 M HEPES buffer in a 
plastic vial. After 30 min, 2 µl of the supernatant of the centrifuged gold ion precursor solution 
was added to the peptide conjugate solution. The mixture was vortexed for a few seconds and 
then left undisturbed at room temperature for one day and TEM samples were prepared.  
Note: When peptide conjugates 2, 3, 4 and 5 were used, similar reaction conditions were 
employed. 
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3.0  HOLLOW SPHERICAL GOLD NANOPARTICLE 
SUPERSTRUCTURES WITH TUNABLE DIAMETERS AND VISIBLE TO 
NEAR-INFRARED EXTINCTION 
A portion of this work, written in collaboration with Yong Zhou, Andrea Merg, Chengyi Song, 
George C. Schatz and Nathaniel L. Rosi*, was published in Nanoscale 2014, 6, 12328. 
3.1 INTRODUCTION 
Hollow spherical nanoparticle assemblies 33,74,83,84,106-115 are attracting widespread interest from 
multiple research communities because of their potential use as theranostic materials,33,106-112,115 
heterogeneous catalysts,116 and metamaterials.117,118 Hollow spherical gold nanoparticle 
assemblies, for example, have shown promise for drug delivery and as agents for photothermal 
therapy;33,106,108,109,112 for the latter, structures absorbing in the near-infrared (NIR) window 
(~650-900 nm) are particularly relevant, because biological tissue does not significantly absorb 
in this region of the spectrum.3 In addition, large spherical assemblies of gold nanoparticles are 
known to display a significant magnetic dipole response in the visible, an important property for 
‘perfect imaging’.117,118 Spherical assemblies of catalytic nanoparticles can show improved 
properties compared to individual nanoparticles. For example, the Rosi Group recently 
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demonstrated that hollow spherical CoPt nanoparticle superstructures exhibit enhanced catalytic 
properties compared to discrete, non-assembled CoPt nanoparticles.116 Here, I present 
straightforward methods for preparing hollow spherical gold nanoparticle superstructures having 
three different diameters: ~40 nm, ~75 nm, and ~150 nm. I report the size-dependent optical 
extinction properties for this class of nanoparticle assemblies, which are tunable from the visible 
and into the NIR.  Additionally, I present computational models developed by our collaborators 
that assist in understanding these important collective optical properties. This work provides a 
practical route for preparing a family of spherical nanoparticle superstructures having tailorable 
diameters and optical properties.   
My motivation for fabricating spherical nanoparticle assemblies derives not only from 
their potential practical importance, but also from a fundamental interest in designing 
nanoparticle superstructures and controlling their compositions, morphologies, structural metrics, 
and physical properties. It is understood that the properties of nanoparticle superstructures 
originate from the size, shape, and compositions of the component nanoparticles as well as the 
precise organization of the nanoparticles within the superstructures.79,81,119 In order to design and 
prepare unique nanoparticle superstructures and control their physical properties, the Rosi Group 
has developed a peptide-based method for directing the synthesis and assembly of inorganic 
nanoparticles.53 Briefly, this method utilizes peptide conjugate molecules that are designed to not 
only bind to the surface of specific inorganic nanoparticles, but also direct the assembly of these 
nanoparticles into particular target nanoparticle superstructures. The peptide portion of the 
peptide conjugate molecule binds to the nanoparticle surface,34,51,52,120-122 while an organic 
molecule (e.g. an aliphatic chain) tethered to the peptide’s N-terminus influences the assembly of 
the peptide conjugate. The group has successfully used this methodology to prepare a diverse 
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collection of nanoparticle superstructures with tunable compositions, morphologies, metrics, and 
properties.53,72-75,83,116,123   
In 2010, the Rosi Group reported that C6-AA-PEPAu conjugates (C6 = C6H11O, A = 
alanine, PEPAu = AYSSGAPPMPPF)
52 direct the synthesis and assembly of hollow spherical 
gold nanoparticle superstructures.74 These structures consisted of ~8 nm gold nanoparticles 
arranged in a monolayer shell around a spherical vesicular self-assembled peptide conjugate core. 
Unique aspects of these structures included their small diameter (~50 nm) and hollow interior, 
which pointed toward their potential application as nanoscale carriers for drugs or other cargo.  
After this initial report, the group also demonstrated that BP-Ax-PEPAu (C12H9CO–Ax–
AYSSGAPPMPPF; x = 2 or 3; BP = biphenyl) could also direct the formation of spherical gold 
nanoparticle superstructures and that the number of additional alanine residues at the N-terminus 
(2 or 3) controls the diameter of the spherical superstructures (large, >100 nm or small, ~30 
nm).75   Based on this prior work, one can fabricate hollow spherical nanoparticle superstructures 
with three different diameters; however, each superstructure requires synthesis of a unique 
peptide conjugate molecule, which is practically limiting. Ideally, a single peptide conjugate 
should be capable of directing the formation of spherical superstructures with different diameters, 
provided that one can control the assembly conditions of the peptide conjugate and the diameter 
of its resulting spherical soft assembly (micelle or vesicle, for example) and the synthetic 
conditions for preparing the nanoparticle superstructure. In this chapter, I demonstrate that C6-
AA-PEPAu can be used to direct the synthesis and assembly of three different size classes of 
hollow spherical gold nanoparticle superstructures. I highlight the role of synthesis and assembly 
conditions in controlling the diameter of the spheres; I use UV-Vis spectroscopy to study their 
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diameter-dependent optical properties; and I present computational models to understand their 
visible and NIR extinction.   
3.2 RESULTS AND DISCUSSION 
The sphere syntheses are straightforward and require minimal synthetic effort. The three 
principal components of the syntheses are i) the peptide conjugate (in this case C6-AA-PEPAu), 
which serves as the particle binding agent and as the structure-directing agent; ii) 4-(2-
hydroxyethyl)-piperazineethanesulfonic acid (HEPES) buffer (pH= 7.3 ± 0.1), which serves as 
the medium for self-assembly and as the primary reducing agent for Au3+;52,124 and iii) a solution 
of chloroauric acid in 1.0 M triethylammonium acetate buffer (HAuCl4/TEAA), which is the 
source of gold ions.74 These components are combined together in one pot to yield a product 
nanoparticle superstructure. In order to prepare batches of spherical nanoparticle superstructures 
having different average diameters using C6-AA-PEPAu, I systematically varied conditions such 
as the concentrations of C6-AA-PEPAu, HEPES buffer, and HAuCl4/TEAA. Careful adjustment 
of these conditions should allow for control over the diameter of the spherical C6-AA-PEPAu soft 
assembly that would ultimately serve as the underlying ‘template’ onto which the nanoparticles 
would assemble. I began by studying the effect of HEPES buffer concentration on the soft 
assembly of a fixed amount of C6-AA-PEPAu. I dispersed 1.87 × 10
-8 mol C6-AA-PEPAu in 125 
μL of four different concentrations of HEPES buffer (0.1, 0.05, 0.01, and 0.005 M) and studied 
their assemblies using transmission electron microscopy (TEM). At specific time points, samples 
of each solution were spotted onto formvar-coated copper TEM grids and stained using 
phosphotungstic acid. At the highest concentration of HEPES (0.1 M), no assemblies were 
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observed, even after 1 week of incubation at room temperature. Large spherical structures (~500 
nm diameter) were observed for the 0.05 M sample after 1 day, and a distribution of spherical 
structures of different diameters were observed after 6 hours and 30 minutes for the 0.01 M and 
0.005 M samples, respectively (Figure 23). From these data, I conclude that the assembly of C6-
AA-PEPAu occurs more rapidly at lower HEPES concentrations than at higher concentrations. 
From previous studies,53,72-75,79,81,83,116,119,123 I determined that the HEPES buffer assists in 
dissolving the peptide conjugates; therefore, I reason that the conjugates assemble more rapidly 
at lower HEPES concentrations because they are less soluble at these concentrations. I concluded 
that HEPES concentration is an important variable that influences the assembly of C6-AA-PEPAu.   
 
 
 
Figure 23. Negatively-stained TEM images of peptide conjugate assemblies at varied HEPES 
concentrations and incubation periods: a) 0.05 M of HEPES buffer, 1 day; b) 0.01 M of HEPES buffer, 6 h; c) 0.005 
M of HEPES buffer, 30 min. 
 
I next studied the assembly of C6-AA-PEPAu dissolved in a fixed amount and 
concentration of HEPES buffer (125 μL, 0.05 M) and with the addition of a fixed amount of 
HAuCl4/TEAA (0.6 μL of a 0.1 M solution of HAuCl4 in 1.0 M TEAA buffer, pH = 7.0).  After 
30 minutes of incubation at room temperature, I observed large spherical assemblies (diameter = 
109 ± 21 nm) at C6-AA-PEPAu concentrations between 100 and 150 μM and smaller spherical 
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assemblies (diameter = 27 ± 8 nm) at C6-AA-PEPAu concentrations between 25 and 75 μM 
(Figure 24). After 4 hours of incubation, I only observed smaller spherical assemblies for each 
of the studied peptide conjugate concentrations. In the negatively-stained TEM images, I observe 
gold nanoparticles assembling around the smaller assemblies. I concluded from these data that, at 
0.05 M HEPES buffer concentration and in the presence of HAuCl4/TEAA, C6-AA-PEPAu will, 
over time, assemble into small spherical assemblies.  Moreover, these assemblies will gradually 
be coated by gold nanoparticles. In fact, after 24 hours of incubation, all of the small spherical 
assemblies are fully coated with gold nanoparticles. These observations revealed a clear path to 
the synthesis and assembly of ‘small’ spherical nanoparticle superstructures. Thus, dissolving 
C6-AA-PEPAu (3.74 × 10
-8 mol) in 0.05 M HEPES buffer, adding an aliquot of HAuCl4/TEAA 
solution, and incubating the resulting mixture for 24 h at room temperature yielded small 
spherical nanoparticle superstructures with an average diameter of 40.4 ± 5.9 nm (Figure 24a-b 
and Figure 25). The gold nanoparticles have an average diameter of 6.2 ± 0.9 nm and the 
average observable interparticle distance (gap) is 2.4 ± 0.6 nm (Figure 26).  While I observe 
some free nanoparticles in the TEM images, the spherical superstructures comprise the major 
product.  A negatively-stained image of a sample from the reaction after 4 hours of incubation 
indicates that the structures consist of nanoparticles surrounding peptide conjugate cores; I 
therefore describe the product as hollow spherical nanoparticle superstructures (Figure 27).   
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Figure 24. (a) Negatively-stained TEM images of peptide conjugate assemblies after adding 
HAuCl4/TEAA and incubating at room temperature for 30 min. The concentration of C6-AA-PEPAu is 100 μM; (b) 
Negatively-stained TEM images of peptide conjugate assemblies after adding HAuCl4/TEAA and incubating at 
room temperature for 30 min. The concentration of C6-AA-PEPAu is 25 μM; (c) Diameter distribution for image (a): 
109 ± 21 nm, based on 100 counts;  (d) Diameter distribution for image (b): 27 ± 8 nm, based on 100 counts; (e) 
Diagram summarizing peptide conjugate assembly in the presence of HAuCl4/TEAA (incubation time versus 
concentration of C6-AA-PEPAu): red square, large spheres; green circle, small spheres; navy X, free nanoparticles 
and small spherical nanoparticle superstructures. 
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Figure 25. TEM images of hollow spherical gold nanoparticle superstructures. (a,b) Small, (c,d) 
medium, and (e,f) large. 
 
 53 
 
 
Figure 26. (a-c) Additional TEM images of small spherical nanoparticle superstructures. (d) Distribution of 
gold nanoparticle diameter within the superstructures: 6.2 ± 0.9 nm, based on 100 counts; (e) Distribution of 
interparticle distances (gap) within the superstructures: 2.4 ± 0.6 nm, based on 100 counts; (f) Diameter distribution: 
40.4 ± 5.9 nm, based on 100 counts.  Note:  these TEM images, along with those in Figure 1 of the manuscript, were 
obtained from multiple different sphere syntheses. 
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Figure 27. Negatively-stained TEM image of small spherical nanoparticle superstructures in 0.05 M of 
HEPES after adding HAuCl4/TEAA and incubating at room temperature for 4 hours. 
 
While I do not observe C6-AA-PEPAu assemblies in 0.1 M HEPES buffer (vide supra), I 
do observe the formation of hollow spherical nanoparticle assemblies after the addition of 
HAuCl4/TEAA and subsequent incubation at room temperature (Figure 28).  Because I do not 
observe peptide conjugate assembly prior to the addition of HAuCl4/TEAA, I suspect that C6-
AA-PEPAu assembly and nanoparticle formation occur simultaneously and that nanoparticle 
synthesis and assembly is a coupled process; however, at this stage, this is a hypothesis. Hollow 
spherical nanoparticle superstructures with average diameter of 75.3 ± 12.4 nm were formed 
after dissolving C6-AA-PEPAu (1.87 × 10
-8 mol) in 0.1 M HEPES (125 μL), adding an aliquot of 
HAuCl4/TEAA, and incubating for 3 days at room temperature. To minimize aggregation of the 
product structures, cetyl trimethylammonium bromide (CTAB) was added to the solution after 3 
days.125 During optimization of the synthesis, I observed that very small differences in the 
amount of added HAuCl4/TEAA significantly affect structural factors such as particle size and 
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particle density within the product. I found that smaller amounts of HAuCl4/TEAA yield more 
well-defined and well-dispersed spherical superstructures, while larger amounts of 
HAuCl4/TEAA yield aggregated superstructures that are more densely loaded with nanoparticles 
(Figure 29). Ultimately, I determined that the addition of 0.7 μL of the HAuCl4/TEAA solution 
yields the most uniform product (Figure 25c-d and Figure 30). The average size of the 
nanoparticles comprising these structures is 8.5 ± 1.5 nm and the observable interparticle 
distance (gap) is 1.5 ± 0.3 nm (Figure 30).  
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Figure 28. Negatively-stained TEM image of medium spherical nanoparticle superstructures after adding 
HAuCl4/TEAA and incubating at room temperature for 4 hours. 
 
 
 
 
 
Figure 29. TEM image of medium spherical nanoparticle superstructures prepared using different amounts 
of HAuCl4/TEAA after one day of incubation at room temperature: a) 0.5 μL HAuCl4/TEAA; b) 1.0 μL 
HAuCl4/TEAA. 
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Figure 30. (a-c) Additional TEM images of medium spherical nanoparticle superstructures. (d) Distribution 
of gold nanoparticle diameter within the superstructures: 8.5 ± 1.5 nm, based on 100 counts; (e) Distribution of 
interparticle distances (gap) within the superstructures: 1.5 ± 0.3 nm, based on 100 counts; (f) Diameter distribution: 
75.3 ± 12.4 nm, based on 100 counts. Note:  these TEM images, along with those in Figure 1 of the manuscript, 
were obtained from multiple different sphere syntheses. 
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Having prepared both small (~40 nm) and medium (~75 nm) diameter spherical 
superstructures, I next explored the synthesis of larger spheres (>100 nm) using the same C6-AA-
PEPAu peptide conjugate. I observed that C6-AA-PEPAu assembles into large spherical 
assemblies (diameter = 240 ± 81 nm) when dissolved in mixtures of 0.1 M HEPES and 1.0 M 
TEAA buffer (Figure 31), which stands in contrast to what I observed in pure 0.1 M HEPES 
(vide supra). When an aliquot of aqueous HAuCl4 is added to the solution of C6-AA-PEPAu in 
HEPES/TEAA, I again observe the formation of large spheriocal peptide conjugate assemblies 
(diameter = 236 ± 75 nm, Figure 32) after 4 hours of incubation at room temperature. After 24 
hours of incubation, large hollow spherical gold nanoparticle superstructures having an average 
diameter of 149.7 ± 30.8 nm were observed (Figure 25e-f, and Figure 33). These structures 
consist of gold nanoparticles with an average diameter of 9.9 ± 1.6 nm and an average 
observable interparticle distance (gap) of 1.6 ± 0.3 nm (Figure 33). I conclude that the particles 
assemble around the peptide conjugate spherical assembly based on examination of negatively-
stained images of a sample taken from the reaction after 10 hours of incubation (Figure 34). The 
thickness of the gold nanoparticle shell suggests that ~2 layers of nanoparticles surround the 
peptide conjugate core. In summary, I have shown that a single peptide conjugate, C6-AA-PEPAu, 
can be used to prepare small, medium, and large spheres simply by modifying the synthesis and 
assembly conditions (Scheme 3). 
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Figure 31. (a) Negatively-stained TEM images of 150 μM C6-AA-PEPAu assembly in HEPES/TEAA 
mixture after 4 hour incubation at room temperature; (b) Diameter distribution of these assemblies: 240 ± 81 nm, 
based on 100 counts. 
 
 
 
 
 
 
Figure 32. (a) Negatively-stained TEM image of C6-AA-PEPAu assembly in HEPES/TEAA mixture after 
adding aqueous HAuCl4 solution and incubating for 4 hours at room temperature; (b) Diameter distribution of these 
assemblies: 236 ± 75 nm, based on 100 counts. 
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Figure 33. (a-c) Additional TEM images of large spherical nanoparticle superstructures. (d) Distribution of 
gold nanoparticle diameter within the superstructures: 9.9 ± 1.6 nm, based on 100 counts; (e) Distribution of 
interparticle distances (gap) within the superstructures: 1.6 ± 0.3 nm, based on 100 counts; (f) Diameter distribution: 
149.7 ± 30.8 nm, based on 100 counts. Note:  these TEM images, along with those in Figure 1 of the manuscript, 
were obtained from multiple different sphere syntheses. 
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Figure 34. Negatively-stained TEM image of large spherical nanoparticle superstructures in HEPES/TEAA 
mixture after adding HAuCl4 aqueous solution and incubating for 10 hours at room temperature. 
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Scheme 3. Direct preparation of hollow spherical gold nanoparticle superstructures with different diameters 
using C6-AA-PEPAu (yellow spheres = Au nanoparticles). 
 
Assemblies of plasmonic nanoparticles often exhibit emergent collective optical behavior 
dependent on the composition and structure of the assembly.19,20 Moreover, continuous gold 
nanoshells grown on spherical silica bead templates are known to have NIR extinction.15 I was 
keen to measure the absorption properties of the prepared hollow spherical nanoparticle 
superstructures and to understand the origin of these properties. The UV-Vis spectra for each 
sample were found to have maxima at 545 nm, 670 nm, and 740 nm, respectively (Figure 35a), 
indicating substantial shifts from the isolated gold nanoparticle plasmon wavelength of 520 nm, 
and increasing red-shift with increasing superstructure size. The extinction peak for the small 
spheres was much narrower than that observed for the medium and large spheres, which both 
exhibited very broad extinction ranging from 500-950 nm. I attribute this broad signal to 
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polydispersity of the samples and coupling between the surface plasmons of the individual 
nanoparticles.  I note that the extinction maximum for the large spheres (740 nm) lies in the NIR, 
which may prove useful for biological applications.33,106-109 
 
 
 
Figure 35. (a) Experimental UV-Vis spectra of hollow spherical gold nanoparticle superstructures 
with varied sizes. The extinction maxima of small, medium and large gold nanospherical superstructures are 
observed at 545 nm (blue), 670 nm (green) and 740 nm (red) respectively. (b) Theoretical extinction spectra 
for the same superstructures, where the small superstructure is modeled using GMM (taking gap parameters 
from Table 1) and the medium and large superstructures are modelled using Mie theory for a spherical 
metal shell structure. 
 
Electrodynamics calculations have been carried out so as to relate the experimentally 
observed UV-Vis spectra to structural details of the assemblies. Given that the superstructures 
appeared to be composed of closely spaced but not necessarily overlapping gold particles,  the 
General Multiparticle Mie (GMM) method126-129 was first adopted for these calculations as this 
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provides an exact solution to Maxwell’s equations for an assembly of non-overlapping spherical 
nanoparticles. 
The structural parameters used in the simulations are from the experimental 
measurements, as summarized in Table 1. In the absence of structural details beyond what is 
pictured in the TEM images (e.g. Figure 25), it is justified to assume that the nanoparticles are 
randomly distributed on the surface of the superstructure.  This leads to approximately 32, 132, 
and 764 gold nanoparticles for the small, medium, and large superstructures, respectively. Also, 
the observations suggest that the small and medium superstructures have monolayer coverage of 
gold nanoparticles while the large superstructures are consistent with two layers of nanoparticles. 
Tabulated gold dielectric constants from Johnson and Christy were used, with a correction to the 
imaginary part of the dielectric constant to include for surface scattering of the conduction 
electrons.130-133 The refractive index n of the peptide core was chosen to be 1.6, a typical value 
used previously.134 The surrounding medium was assumed to be water with n=1.33. 
 
Table 1. Diameters of the superstructures, diameters of the gold nanoparticles , and observable interparticle 
distances (gaps). 
 
Superstructures Spheres (nm) Nanoparticles (nm) Gaps (nm) 
Small 40.4 ± 5.9 6.2 ± 0.9 2.4 ± 0.6 
Medium 75.3 ± 12.4 8.5 ± 1.5 1.5 ± 0.3 
Large 149.7 ± 30.8 9.9 ± 1.6 1.6 ± 0.3 
 
Normalized extinction spectra calculated using the GMM method are shown in Figure 36. 
The simulated extinction spectra for the small superstructures peak at 540 nm, which is quite 
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close to the experimental value, 550 nm. The plasmon maxima for the larger superstructures are 
red-shifted as expected, however the red shift is significantly smaller than what is observed in the 
experiments (Figure 35a). One possible explanation for this difference in the amount of plasmon 
band red-shifting is that the real size of the interparticle gaps may be smaller than those 
measured in the TEM images. Indeed, most interparticle gaps are not clearly defined in the TEM 
images. To modify the electrodynamics modelling calculations using GMM with smaller gaps 
were performed. As shown in Figure 36, even with gaps decreased down to 1 nm, the calculated 
SPRs, located at 570 nm and 640 nm for medium and large superstructures, are still far from the 
experimental observations (670 nm and 740nm). 
 
 
 
Figure 36. Extinction spectra of hollow spherical gold nanoparticle superstructures calculated using 
General Multiparticle Mie method. Component nanoparticles are assumed to be fully isolated in the simulation, with 
interparticle gaps from experimental measurement (see Table 1). 
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For gaps of less than 1 nm, classical theories such as the GMM method are no longer 
valid due to the onset of quantum effects. Nordlander and co-workers studied the plasmon 
resonance properties of a nanoparticle dimer using time-dependent density functional theory 
(TD-DFT), and found that the red-shifting trend with decreasing interparticle gap is reversed for 
dimer separations below 1 nm.135 There is also experimental evidence supporting this result.129,136 
Additional resonances, denoted charge transfer plasmons, also appear for small gaps,137 including 
one that is red-shifted relative to the red-most classical resonance. Charge transfer plasmons are 
often described as arising from electron tunnelling between the nanoparticles, and as a 
consequence there is extreme sensitivity of the energies of these resonances to gap size. Because 
of this, it is impractical to estimate spectra based on such models.  
A much simpler explanation is that the gold nanoparticles are touching or may be 
partially fused together instead of being fully isolated from each other (Figure 25b, d, and f). 
This leads to the formation of a quasi-continuous gold shell with defects such as pinholes. In a 
previous study on the optical properties of metal nanoshells, Hao et al found that the effect of 
such small pinholes on the extinction maxima is small.138 Thus, in the extinction spectrum 
simulation, the defected quasi-continuous gold shell can be simplified to a perfect continuous 
spherical shell. The thickness of the equivalent gold shell is determined by the average diameter 
of the component gold nanopartlces which was taken to be 8.5 nm and 20 nm for the medium 
and large superstructures, respectively. The optical response of the resulting core-shell structure 
can readily be studied by Mie theory.139 
The extinction spectra calculated using this continuous shell model are shown in Figure 
37. The medium and large superstructures show plasmon resonances at 675 nm and 730 nm, 
respectively, which are in quite good agreement with the experimentally observed values (670 
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nm and 740 nm). Figure 35b shows calculated spectra analogous to the corresponding 
experiments in Figure 35a, with the small superstructure calculated using GMM while the 
medium and large superstructures are from Mie theory (and it is noted that the small 
superstructure is also well-described as a continuous shell with a 7.0 nm thickness). The 
comparison between theory and experiment is excellent, thus indicating that the continuous shell 
model is an accurate representation of the plasmonic properties of the superstructures. 
Differences in the plasmon widths in Figure 35a and 35b are due to polydispersity, as mentioned 
earlier. 
 
 
 
Figure 37. Extinction spectra of hollow spherical gold nanoparticle superstructures calculated using Mie 
theory. Component nanoparticles are assumed to be fused together. The spherical layer of gold nanoparticles is 
simplified as a continuous gold shell in the simulation, with the shell thickness determined by the average diameter 
of gold nanoparticles (see Table 1). 
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3.3 CONCLUSION 
In summary, hollow gold nanoparticle superstructures with varied diameters (~40 nm, ~75 nm, 
and ~150 nm) and surface plasmon resonance (SPR) responses have been prepared by using a 
single peptide conjugate, C6-AA-PEPAu. The SPR bands red-shift and broaden as the diameters 
of the spheres and individual gold nanoparticles increase. Medium (75.3 ± 12.4 nm) and large 
(149.7 ± 30.8 nm) spheres each display broad SPR peaks in the NIR window (650-900 nm), 
pointing toward their potential for biological applications. A shell model was used to 
successfully simulate the optical properties of these materials. The success of this model in 
explaining the large SPR red-shifting of the medium and large spheres implies that they are 
likely composed of a quasi-continuous shell structure with defects such as pinholes.  Moreover, 
the shell model can be used to develop design rules for synthesizing new superstructures. 
3.4 EXPERIMENTAL SECTION 
3.4.1 Materials and methods 
All solvents and chemicals were obtained from commercial sources and used without further 
purification. 0.1M HEPES Buffer (HEPES = 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid) was made by directly diluting 1.0 M HEPES buffer (pH = 7.3 ± 0.1; Fisher Scientific) with 
water (NANOpure, Barnstead DiamondTM System.; 18.2 MΩ). Peptide (AAAYSSGAPPMPPF 
or AA-PEPAu) was synthesized and purified by New England Peptide with final purity of 99%. 
Reverse-phase high-pressure liquid chromatography (HPLC) was performed at ambient 
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temperature with an Agilent 1200 liquid chromatographic system equipped with diode array and 
multiple wavelength detectors using a Grace Vydac protein C4 column (214TP1010, 1.0 cm × 25 
cm). Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectra were 
obtained using an Applied Biosystem Voyager System 6174 MALDI-TOF mass spectrometer 
using α-cyano-4-hydroxy cinnamic acid (CHCA) as the matrix. Transmission electron 
microscopy (TEM) samples were prepared by pipetting one drop of solution onto a 3-mm-
diameter copper grid coated with carbon film; 2% aqueous phosphotungstic acid was used for 
negative staining. TEM was conducted on either a JEOL 200CX instrument operated at 200 kV 
and equipped with a Gatan CCD image system or FEI Morgagni 268 operated at 80kV and 
equipped with an AMT side mount CCD camera system. UV-Vis spectra were collected using an 
Agilent 8453 UV-Vis Spectrometer with a quartz cuvette (10 mm pass length) at room 
temperature. 
3.4.2 Preparation of N-hydroxyl-succinimide ester and peptide conjugates 
N-hydroxyl-succinimide esters. Caproic acid (1.16 g, 10.0 mmol) and N-hydroxysuccinimide 
(1.18 g, 10.3 mmol) were dissolved in 100 mL dry ethyl acetate under an argon atmosphere. 
After addition of dicyclohexyl carbodiimide (DCC) (2.16 g, 10.5 mmol) at 0ºC, the solution was 
stirred overnight at room temperature. The reaction mixture was processed by removing the 
precipitate via filtration. The solvent was removed under reduced pressure and the crystalline 
residue was recrystallized from isopropanol (iPrOH) to yield the N-hydroxyl-succinimide ester 
(506 mg, 1.44 mmol, 25%). 
Peptide conjugates. AAAYSSGAPPMPPF (1.20 mg, 8.80 ×10-7 mol) was dissolved in 60 μL 
dimethylformamide (DMF). After addition of caproic N-hydroxyl-succinimide ester (0.6 mg, 
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2.81×10-6 mol) in 60 μL DMF and 1 μL Et3N under stirring, the solution was stirred at room 
temperature for 17 h. Pure C6-AA-PEPAu was obtained by conducting reversed-phase HPLC 
eluting with a linear gradient of 0.05% formic acid in CH3CN and 0.1% formic acid in water 
(5/95 to 95/5 over 30 min.) (Figure A3). The molecular weight for C6-AA-PEPAu was confirmed 
by MALDI-TOF mass spectrometry (Figure A4). The concentration of the peptide was 
determined spectrophotometrically in water/acetonitrile (1:1) using the molar extinction 
coefficient of tyrosine (1280 M-1cm-1) at 280 nm. 
3.4.3 Preparation of small spheres 
Lyophilized C6-AA-PEPAu (~3.74 × 10
-8 mol) was completely dissolved in 125 μL 0.05 M 
HEPES buffer (pH = 7.3 ± 0.1) in a plastic vial. This peptide solution was allowed to incubate at 
room temperature for 30 min. During the 30 min. incubation time, a fresh gold ion precursor 
solution was prepared: 0.1 M chloroauric acid (HAuCl4) in 1.0 M triethylammonium acetate 
(TEAA; pH = 7.0) buffer was incubated for 10 min. at room temperature. Thereafter, this 
mixture was centrifuged (10 min., 5K rpm). After the 30 min. peptide solution incubation period, 
0.6 μL of the supernatant of the centrifuged gold ion precursor solution was added to the peptide 
conjugate solution. A small amount of black precipitate appears after ~2 s. At that point, the 
mixture was immediately vortexed for 1 min. and then left undisturbed at room temperature for 
one day. Products from multiple syntheses were studied using TEM and UV-Vis spectroscopy. 
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3.4.4 Preparation of medium spheres 
Lyophilized C6-AA-PEPAu (~1.87 × 10
-8 mol) was completely dissolved in 125 μL 0.1 M 
HEPES buffer (pH = 7.3 ± 0.1) in a plastic vial. This peptide solution was allowed to incubate 
for 30 min. at room temperature. During the 30 min. incubation time, a fresh gold ion precursor 
solution was prepared: 0.1M chloroauric acid (HAuCl4) in 1.0 M triethylammonium acetate 
(TEAA; pH = 7.0) buffer was incubated for 10 min. at room temperature. Thereafter, this 
mixture was centrifuged (10 min., 5K rpm). After the 30 min. peptide solution incubation period, 
0.7 μL of the supernatant of the centrifuged gold ion precursor solution was added to the peptide 
conjugate solution. A small amount of black precipitate appears after ~2 s. At that point, the 
mixture was immediately vortexed for 1 min. and then left undisturbed at room temperature for 3 
days. Afterwards, 1 μL of 0.1 M cetyltrimethylammonium bromide (CTAB) solution was added 
and then vortexed for 1 min., leading to the final concentration of 0.8 mM of CTAB. Products 
from multiple syntheses were studied using TEM and UV-Vis spectroscopy. 
3.4.5 Preparation of large spheres 
Lyophilized C6-AA-PEPAu (~1.87 × 10
-8 mol) was completely dissolved in 110 μL 0.1 M 
HEPES buffer and 15 μl 1.0 M TEAA buffer (pH= 7.3 ± 0.1)  in a plastic vial. This peptide 
solution was allowed to incubate for 30 min. Thereafter, 4 µl of 0.01 M chloroauric acid 
(HAuCl4) aqueous solution was added to the above solution. The mixture was immediately 
vortexed for 1 min. and then left undisturbed at room temperature for one day. Products from 
multiple syntheses were studied using TEM and UV-Vis spectroscopy. 
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Note on sphere syntheses: Some batch-to-batch variation in product was observed, in particular 
for the large spheres where I often observe a broad distribution of sphere diameters.  I attribute 
this variation to the small reaction scale and the small amounts of added reagents.   
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4.0  HOLLOW SPHERICAL GOLD NANOPARTICLE 
SUPERSTRUCTURES WITH SIZE-DEPENDENT ENZYMATIC 
STABILITY AND LASER-TRIGGERED DRUG RELEASE 
A portion of this work, in collaboration with Thomas Brinzer, Chong Liu, Sean Garrett-Roe, and 
Nathaniel L. Rosi*, is a manuscript in preparation. 
4.1 INTRODUCTION 
Targeted drug delivery to specific organs and tissues, especially cancer cells, is a critically 
important challenge that, if achieved, could revolutionize disease treatment.140-142 Typical 
nanostructures for drug delivery include vesicles, inorganic nanoparticles, and nanoparticle 
assemblies. Molecular vesicles, such as liposomes, have shown great potential in drug delivery 
due to their biocompatibility, easy preparation, non-specificity to drugs, and their ability to 
enhance the solubility of drugs.143 However, liposomes encounter difficulties when orally 
delivered due to their poor stability under physiological conditions.144 Also, their pharmaceutical 
use is limited due to drug molecule leakage via diffusion during the delivery process, as well as 
the low drug loading efficiency and poorly controlled release.144 Other disadvantages include 
poor protection of drug molecules, aggregation of vesicles into larger particles, and difficulties in 
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scale-up production.145,146 Inorganic nanoparticles emerged decades ago as drug delivery systems 
as well as imaging and diagnostic agents. Metal nanoparticles, especially gold nanoparticles, 
such as spherical gold nanoparticles, gold nanorods, gold nanoshells, and gold nanoboxes have 
been widely studied for drug delivery.147 The surface of gold nanoparticles can be easily 
modified with functional molecules bearing thiol groups, which makes gold nanoparticles 
promising candidates for drug delivery applications. For instance, the modification of PEG can 
enhance the stability and biocompatibility of gold nanoparticles. In addition, gold nanoparticles 
can be modified with an antibody or peptide to target specific tissues or conjugated with drug 
molecules. More importantly, because of the strong SPR absorbance in near-infrared (NIR) 
region and efficient conversion into local heat, gold nanorods, nanoshells, and nanoboxes can 
serve as theranostic agents for drug delivery.147 However, since the drugs are attached to the 
surface of the gold nanoparticles and exposed to the external environment, the problem of 
leakage and stability of drugs needs to be considered for these systems. Spherical gold 
nanoparticle assemblies,33,74,75,106,108-110,114,148-151 having hollow cores and near-infrared (NIR) 
extinction represent a third class of nanostructures for drug delivery. They combine the 
properties of nanoparticles and liposomes. Their exterior surface can be decorated with specific 
targeting molecules, their hollow interiors can be loaded with therapeutics, and NIR irradiation 
can be used both to stimulate local heating and to trigger drug release via structural degradation. 
Furthermore, the relatively large size of spherical gold nanoparticle assemblies may extend their 
retention time in tumor tissue.152 After structural degradation triggered by NIR irradiation, the 
resulting small nanoparticles can be easily cleared out of human body.152 All of the above 
suggest that hollow spherical gold nanoparticle assemblies are promising candidates as 
theranostic materials, which couple imaging, therapeutic deliver, and photothermal therapy. 
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The Rosi Group have developed peptide-based methods for assembling gold 
nanoparticles into hollow spherical gold nanoparticle superstructures. Generally, this method 
utilizes peptide conjugate molecules that consist of inorganic-binding peptide portion and 
assembly-assisting organic moiety. The peptide portion, which can bind to specific nanoparticle 
surfaces, is selected initially from phage display,34,51,52,120-122 while an organic molecule is 
tethered to influence the assembly of the peptide conjugate.67,98,153 By using this methodology, 
the group has successfully prepared a diverse family of nanoparticle superstructures with tunable 
compositions, morphologies, structural metrics and properties. In Chapter 3, I demonstrated the 
use of C6-AA-PEPAu for the syntheses of hollow spherical nanoparticle superstructures with 
different diameters.151 Small (~40 nm), medium (~75 nm), and large (~150 nm) spheres were 
synthesized. In particular, the medium and large spheres attract considerable interest due to their 
broad surface plasmon resonance (SPR) extinction centered at ~670 nm and ~740 nm 
respectively, which lies in the NIR window of the spectrum.  
In this study, I demonstrated that these gold hollow spheres can be loaded with drug 
molecules. They exhibit size-dependent stability in the presence of a non-specific enzyme, 
proteinase K. The medium spheres are much more stable than the large spheres upon incubation 
with proteinase K. Furthermore, both types of spheres show no obvious structural degradation 
and resulting drug release in acidic medium. In addition, NIR laser irradiation (805 nm) was used 
to degrade both large and medium spheres and triggered the release of drug into solution. As one 
class of the hollow spherical gold nanoparticle assemblies, these innovative structures can be 
potentially used as theranostic agents for a combination therapy coupling both imaging and 
therapeutics. Moreover, the composition of these spheres (peptide conjugate and gold 
nanoparticles) make the structures potentially suitable for applications in biological tissue. It is 
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noted that the sub-100 nm size and the enzymatic stability of medium spheres make them 
particularly attractive and potentially advantageous compared to other known hollow spherical 
gold nanoparticle assemblies. 
4.2 RESULTS AND DISCUSSION 
In prior chapter, I already showed the NIR extinction of both medium spheres and large 
spheres.151 In order to study their potential application as delivery vehicles, I first tested the 
stability of the spheres in the presence of enzyme and laser irradiation. Thereafter, I synthesized 
the drug-loaded spheres and studied their drug-release properties upon incubation with enzyme 
and laser irradiation. 
Large spheres and medium spheres were prepared using the reported method in Chapter 3 
(see experimental section for details). The diameters of the as-synthesized large and medium 
spheres are 155.4 ± 33.7 nm and 72.3 ± 15.2 nm (each based on 100 counts). The diameters of 
nanoparticles of large spheres and medium spheres are 11.0 ± 2.3 nm and 8.3 ± 1.6 nm, 
respectively (each based on 100 counts).  
Compared with soft vesicular drug carriers, such as liposome and vesicles from 
amphiphilic polymers, which exhibit poor stability under the physiological conditions,143,144 
hollow spherical gold nanoparticle superstructures are much more stable. However, since  
peptide conjugate molecules were as the structure-directing agents, I was concerned that enzyme 
in our body may digest the peptide and induce the disassembly of the superstructures and 
subsequent drug release before they reach the target. I studied the stability of the medium and 
large spheres upon incubation with Proteinase K.  Proteinase K was chosen because it is a non-
 77 
specific peptidase with a very high specific activity over a wide range of pH, which is suitable 
for HEPES buffer (pH=7.4). First, I tested the stability of C6-AA-PEPAu in the presence of 
proteinase K in HEPES buffer.  An HPLC trace of the sample  (Figure 38) revealed the 
disappearance of C6-AA-PEPAu peak after the addition of proteinase K, indicating that the 
enzyme can digest the peptide under the reaction conditions studied. Next, 5 µl of 20 mg/ml 
proteinase K was directly added to the as-synthesized spheres solution. Thereafter, the mixture 
was incubated at 37 °C for 24 h. Transmission electron microscopy (TEM) and UV-Vis 
spectroscopy were utilized to monitor the degradation process. Surprisingly, I found that 
proteinase K can only cause the disassembly of large spheres; the medium spheres remain intact. 
Based on the TEM images before (Figure 39a and 39c) and after (Figure 39b and 39d) enzyme 
treatment for one day, I observed no obvious change for medium spheres, while for large spheres, 
spherical gold nanoparticle superstructures fell apart into free nanoparticles. UV-Vis 
spectroscopy was used to monitor the reaction after the addition of enzyme (Figure 39e-f). I 
found similar results with TEM images: the SPR peak of medium spheres only shows a slight 
blue-shift in the spectrum, changing from 670 nm to 665 nm after ~3h, and almost no further 
change after 27 hours, while the large spheres shows decreasing absorption at longer wavelength 
(650-900 nm) and increasing absorption at shorter wavelength (500-650 nm). After 27 hours, the 
large sphere solution only displayed a narrow peak at ~540 nm, which is consistent with the 
presence of free nanoparticles in the TEM image. I speculate that the size of the enzyme (~4 
nm)154 is the limiting factor for the enzyme-induced degradation. Although the average 
observable interparticle distances of medium spheres (1.4 ± 0.3 nm) and large spheres (1.7 ± 0.5 
nm) are both smaller than the size of proteinase K, the medium spheres have more complete and 
well-defined structures so they are much more stable while the large spheres have more defects 
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within their structures that allow the entrance and function of enzyme and are therefore not 
resistant to enzyme degradation. 
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Figure 38. Stability test of C6-AA-PEPAu in 0.1 M HEPES buffer (pH =7) with the addition of proteinase K 
using HPLC: a) C6-AA-PEPAu in 0.1 M HEPES buffer (pH =7); b) C6-AA-PEPAu in 0.1 M HEPES buffer (pH =7) 
after the addition of proteinase K for one day at 37 °C; c) 0.1 M HEPES buffer. The retention time for C6-AA-PEPAu 
is around 16.5 min. 
 
a 
b 
c 
C6-AA-PEPAu 
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Figure 39. TEM images of large spheres (a) before and (b) after the addition of proteinase K for one day; 
TEM images of medium spheres (a) before and (b) after the addition of proteinase K for one day; UV-Vis spectra of 
(e) large spheres and (f) medium spheres after the addition of proteinase K as a function of time. 
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Gold nanoparticles or assemblies, especially those having strong extinction within NIR 
window, can be highly promising for photothermal therapy since they can efficiently convert 
photo energies into heat and increase the local temperature.152 This produced heat can be utilized 
to induce the disassembly of nanoparticle superstructures.33 Therefore, I next investigated the 
laser-induced degradation of medium and large spheres. First, the solutions of as-synthesized 
spheres were irradiated with 805 nm pulsed laser for 10 minutes at different average powers: 
2.59 W and 1.25 W. Both the large spheres and the medium spheres degrade after extended laser 
irradiation. TEM images of the solution were taken after laser irradiation (Figure 40a-d). 
Although many free nanoparticles are observed, there are still a few spherical assemblies 
remaining after irradiation. Irradiation with 2.59 W laser leads to fewer intact spherical 
assemblies compared to solutions irradiated with 1.25 W lasers. Many medium spheres remained 
intact after irradiation with the average power of 1.25 W (Figure 40d). As shown in UV-Vis 
spectra (Figure 39e-f) of both medium and large spheres, after 10 min irradiation at 805 nm, the 
sample exposed to the 2.59 W laser power has a narrower extinction and a greater blue-shift 
compared to the sample exposed to the 1.25 W laser, which indicates the degradation of hollow 
spherical nanoparticle superstructures. By comparing the UV-Vis spectra of medium spheres and 
large spheres at the same power, the large sphere samples show a greater blue-shift, indicating 
that laser irradiation at 805 nm can degrade large spheres more efficiently. I attribute this to the 
wavelength of extinction peak of these spheres: The maximum extinction of the large spheres is 
~740 nm which is closer to 805 nm while the peak of medium spheres is centered at ~670 nm 
which indicates relatively less absorption at 805 nm.155,156 All of the above indicate that laser 
irradiation can lead to efficient degradation of these spherical superstructures. 
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Figure 40. TEM images of (a) large spheres and (b) with 2.59 W laser irradiation for 10 minutes at 805 nm; 
TEM images of (c) large spheres (d) medium spheres with 1.25 W laser irradiation for 10 minutes at 805 nm; UV-
Vis spectra of (e) large spheres and (f) medium spheres at 805 nm with different laser irradiation powers: 2.59 W 
and 1.25 W. 
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I also checked the TEM and UV-Vis data at different time points (2, 4, 6, and 8 minutes) 
during the laser irradiation using 2.59 W at 805 nm (Figure 41). Based on this, I found that, with 
extended laser irradiation times, all the spheres with larger size are degraded, leaving mainly free 
nanoparticles and a few small spherical assemblies. After 8 min, those smaller spherical 
assemblies have average diameters of 42.1 ± 9.5 nm and 43.8 ± 10.0 nm (each based on 20 
counts) for large spheres and medium spheres, respectively.  
 
 
 
Figure 41. (a) TEM image of large spheres and medium spheres with 2.59 W laser irradiation at 805 nm at 
different time points: 2 min., 4 min., 6 min., and 8 min.; (b) UV-Vis spectra of large spheres with 2.59 W laser 
irradiation at 805 nm as a function of time; (c) UV-Vis spectra of medium spheres with 2.59 W laser irradiation at 
805 nm as a function of time. 
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Next, I began to study triggered drug release from these spheres upon the decomposition 
of the superstructure. Doxorubicin (DOX) was selected as the cargo molecule because it is a 
fluorescent anti-cancer drug and it has a peak centered at 485 nm in the UV-Vis spectrum33,109,157 
First, I synthesized the drug loaded large spheres and medium spheres by either loading the drugs 
after the synthesis of spheres (post-synthetic loading) or in situ with the synthesis (see 
experimental section for details). The in situ loading method is commonly used for drug 
encapsulation system, such as liposome, where drug encapsulation and superstructure formation 
occur at the same time.143 I used TEM to confirm the formation of spherical gold nanoparticle 
superstructures when using in situ loading method (Figure 42a-b). The average diameters of 
large spheres and medium spheres are 152.3 ± 32.8 nm and 74.5 ± 14.6 nm (each based on 100 
counts). The diameters of nanoparticles for large spheres and medium spheres are 10.5 ± 2.0 nm 
and 8.5 ± 1.8 nm (each based on 100 counts). This is comparable to the diameters of spheres 
without loading drugs. Next, the loading efficiency was determined by calculating the difference 
between the amount of doxorubicin added and the amount of doxorubicin washed out after 
loading (see experimental section for details). The amount of doxorubicin is determined by the 
absorption at 485 nm in the UV-Vis spectrum and the calibration curve. I found that the loading 
efficiency of post-synthetic loading is 4% for large spheres and 2% for medium spheres, while 
the loading efficiency of in situ loading is 51% for large spheres and 43% for medium spheres 
respectively, which is much higher than encapsulation efficiency using liposome (e.g., 5-15% by 
using the method of thin-film hydration).143 The post-synthetic loading is mainly due to physical 
absorption and slow diffusion of DOX into spherical assemblies while the in situ loading is 
based on in situ absorption and capturing of DOX within the hollow interior, which gives more 
efficient loading of drug molecules. Since the fluorescence of DOX would be quenched within 
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proximity of gold nanoparticles, I measured the fluorescence of the as-synthesized solution to 
evaluate the extent of drug loading. Using doxorubicin in HEPES buffer at the same 
concentration as a control, post-synthesis loading shows a small loss of fluorescence while in situ 
loading method shows much more quenching by gold nanoparticles (Figure 42c-d). In addition, 
large spheres show more quenching than medium spheres. All of these are consistent with the 
loading efficiency determined by UV-Vis spectroscopy.  
 
 
 
Figure 42. TEM images of DOX-loaded (a) large spheres and (b) medium spheres using in situ loading 
method; (c) Fluorescence spectra of large spheres and medium spheres using post-synthetic loading method; (d) 
Fluorescence spectra of as-synthesized large spheres and medium spheres using in situ loading method. 
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Ideally, the drugs should stay within the spheres without leaking during the delivery 
process and before they reach the targeted location. Being aware of the gaps between 
constitutional nanoparticles within the superstructures, I was concerned about the leakage of the 
drug molecules. Therefore, I performed drug leakage tests in different buffers. The DOX-loaded 
spheres were prepared, separated and washed by centrifugation. The remaining solid was re-
dispersed in fresh 0.1 M HEPES buffer (pH = 7) or 0.1 M PBS buffer (pH = 7). The cumulative 
leakage was investigated at different time points. At each time point, the solution was 
centrifuged and the amount of DOX released in the supernatant was determined by comparing its 
absorbance at 485 nm with the calibration curves of DOX using UV-Vis spectrometer. After 
each time point, the remaining solid was re-dispersed in fresh buffers. I did observe some 
leakage of drugs for both large spheres and medium spheres in HEPES buffer and PBS buffer 
(Figure 43a-b). The cumulative release profiles indicate continuous leakage within the first 9 
hours for both large spheres and medium spheres in either HEPES buffer or PBS buffer. In both 
buffers, large spheres show faster and slightly more leakage than medium spheres. After 32 
hours, the final cumulative leakage for large spheres and medium spheres are ~17% and ~13% in 
HEPES buffer, and ~16% and ~14% in PBS buffer. Since tumor tissues are usually acidic by 
hypoxia,152 I also performed the leakage test in acetate buffer (pH = 5) to check whether acidic 
conditions could induce the degradation of these spherical assemblies to release more drug 
(Figure 43c). However, the test shows similar result with those performed in HEPES buffer and 
PBS buffer. In acetate buffer, the final cumulative leakage for large spheres and medium spheres 
are ~20% and ~16%, respectively. The leakage for both large and medium spheres in all three 
buffers are comparable with the reported vesicular gold nanorod assemblies,33 but much smaller 
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than the leakage for soft vesicular drug carriers, such as liposomes which exhibit poor stability 
under the physiological conditions.143,158   
 
 
 
Figure 43. Leakage test of large spheres and medium spheres in different buffers: (a) HEPES buffer (pH = 
7); (b) PBS buffer (pH =7); (c) Acetate buffer (pH = 5). 
 
I already demonstrated that proteinase K can induce the degradation of large spheres but 
is not effective against medium spheres. I next tested whether proteinase K has a similar 
influence on drug-loaded spheres. To the as-synthesized DOX-loaded spheres solution, 5 µl of 
20 mg/ml proteinase K was directly added. Thereafter, the mixture was incubated at 37 °C for up 
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to 34 h.  The release of DOX was determined by measuring the absorption of free DOX at 485 
nm in the supernatant after centrifugation. For the large spheres, the cumulative release profile 
shows continuous release of DOX until it reaches ~70% after 7 hours. Thereafter, DOX 
continues to be released, albeit much more slowly compared to the initial rapid release. (Figure 
44a). A cumulative DOX release of ~73% is achieved after 37 hours. However, DOX-loaded 
medium spheres show only limited release within the first ~6 hours and a final cumulative DOX 
release of 15%, which is comparative to result of the leakage test in HPEPS buffer and PBS 
buffer (Figure 44a).  Therefore, I speculate that the drug release from the medium spheres is 
mainly due to leakage rather than degradation of the superstructure. Cumulative release profiles 
of large spheres and medium spheres in PBS buffer (pH = 7) with the addition of proteinase K 
were also collected and gave similar results with those in HEPES buffer (Figure 44b). The final 
cumulative release of DOX after 32 hours is ~71% for large spheres and ~14% for medium 
spheres, respectively. Fluorescence spectrometry was utilized to monitor the release of DOX 
from as-synthesized drug-loaded spheres upon the addition of proteinase K (Figure 44c-d). The 
fluorescence spectra show consistent results with the cumulative release profiles of large spheres 
and medium spheres.  All of these results indicate the drug-loaded medium spheres are stable in 
the presence of enzyme while large spheres are not. 
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Figure 44. Cumulative release profile with the addition of proteinase K for large spheres and medium 
spheres in (a) HEPES buffer or (b) PBS buffer. Time-dependent fluorescence spectra with the addition of proteinase 
K for (c) large spheres and (d) medium spheres. 
 
Next, I applied laser irradiation at 805 nm and power of 2.49 W to the drug-loaded 
spheres for 10 minutes. Large spheres show a final drug release of 82% and medium spheres 
show the release of 69%. TEM indicates that the spheres degrade under this condition (Figure 
45a-b). In addition, fluorescence spectra show that the fluorescence of DOX is recovered after 
laser irradiation for both large spheres and medium spheres (Figure 45c-d). All of these data 
indicate that laser irradiation in this condition is effective to induce the degradation of both large 
spheres and medium spheres and triggers drug release. 
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Figure 45. TEM images of (a) large spheres and (b) medium spheres with laser irradiation at 805 nm for 10 
minutes. Fluorescence spectra of (c) large spheres and (d) medium spheres before and after laser irradiation at 805 
nm for 10 minutes. 
4.3 CONCLUSION 
In summary, I have successfully prepared spherical gold nanoparticle superstructures with varied 
diameters and Vis-NIR extinction and loaded the spheres with an anticancer drug during the 
synthesis. Their size-dependent enzymatic stability and triggered drug release using laser 
irradiation are demonstrated.  
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4.4 EXPERIMENTAL SECTION 
4.4.1 Materials and methods 
All solvents and chemicals were obtained from commercial sources and used without further 
purification. 0.1M HEPES Buffer (HEPES = 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) 
was made by directly diluting 1.0 M HEPES buffer (pH = 7.3 ± 0.1; Fisher Scientific) with water 
(NANOpure, Barnstead DiamondTM System.; 18.2 MΩ). Peptide (AAAYSSGAPPMPPF or 
AA-PEPAu) was synthesized and purified by New England Peptide with final purity of 99%. 
Reverse-phase high-pressure liquid chromatography (HPLC) was performed at ambient 
temperature with an Agilent 1200 liquid chromatographic system equipped with diode array and 
multiple wavelength detectors using a Grace Vydac protein C4 column (214TP1010, 1.0 cm × 25 
cm). Transmission electron microscopy (TEM) samples were prepared by pipetting one drop of 
solution onto a 3-mm-diameter copper grid coated with carbon film. TEM was conducted on 
either a JEOL 200CX instrument operated at 200 kV and equipped with a Gatan CCD image 
system or FEI Morgagni 268 operated at 80kV and equipped with an AMT side mount CCD 
camera system. UV-Vis spectra were collected using an Agilent 8453 UV-Vis Spectrometer with 
a quartz cuvette (10 mm path length) at room temperature. A commercial Ti:Sapphire laser with 
a 5 kHz  repetition rate was used to generate 100 fs 805 nm laser pulses. A seed pulse from a 
mode-locked Ti:Sapphire oscillator (Coherent Vitesse) is amplified by a chirped-pulsed system 
(Coherent Legend Elite), which is pumped by a frequency doubled Nd:YLF laser. The resulting 
pulses were directed through a 1 cm iris immediately before the sample. Average laser power 
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was measured at the sample, using a thermopile detector (Coherent PowerMax). The 2.59 W 
average power is 0.660 mJ·cm-2 / pulse and the 1.25 W average power is 0.318 mJ·cm-2 / pulse. 
4.4.2 Preparation of large spheres or DOX-loaded large spheres using in situ loading 
method 
C6-AA-PEPAu was synthesized using the previously reported method. Lyophilized C6-AA-PEPAu 
(~1.87 × 10-8 mol) was completely dissolved in 110 μL 0.1 M HEPES buffer and 15 μl 1.0 M 
TEAA buffer in a plastic vial. (For DOX-loaded large spheres, 2 μL 1 mg/mL aqueous 
doxorubicin hydrochloride solution was added and vortexed at this time.) This solution was 
allowed to incubate for 30 min. Thereafter, 4 µl of 0.01 M chloroauric acid (HAuCl4) aqueous 
solution was added to the above solution. The mixture was immediately vortexed for 1 min. and 
then left undisturbed at room temperature for one day. Products from multiple syntheses were 
studied using TEM and UV-Vis spectroscopy. 
4.4.3 Preparation of medium spheres or DOX-loaded medium spheres using in situ 
loading method 
Lyophilized C6-AA-PEPAu (~1.87 × 10
-8 mol) was completely dissolved in 125 μL 0.1 M 
HEPES buffer in a plastic vial. (For DOX-loaded medium spheres, 2 μL 1 mg/mL aqueous 
doxorubicin hydrochloride solution was added and vortexed at this time.) This solution was 
allowed to incubate for 30 min. During the 30 min. incubation time, a fresh gold ion precursor 
solution was prepared: 0.1M chloroauric acid (HAuCl4) in 1.0 M triethylammonium acetate 
(TEAA; pH = 7.0) buffer was incubated for 10 min. at room temperature. Thereafter, this 
 93 
mixture was centrifuged (10 min., 5K rpm). After the 30 min. peptide solution incubation period, 
0.7 μL of the supernatant of the centrifuged gold ion precursor solution was added to the peptide 
conjugate solution. The mixture was immediately vortexed for 1 min. and then left undisturbed at 
room temperature for one day. Products from multiple syntheses were studied using TEM and 
UV-Vis spectroscopy. 
4.4.4 Enzyme treatment of spheres 
To the as-synthesized spheres or DOX-loaded spheres solution, 5 µl of 20 mg/ml Proteinase K 
was directly added. The mixture was incubated at 37 °C for up to 27 h. UV-Vis spectrum was 
taken at different time points. 
4.4.5 Enzyme treatment of DOX-loaded spheres 
To the as-synthesized spheres or DOX-loaded spheres solution, 5 µl of 20 mg/ml Proteinase K 
was directly added. The mixture was incubated at 37 °C for up to 32 h. The release profiles of 
DOX were investigated in HEPES buffer (pH = 7) and PBS buffer (pH = 7). At each time point, 
the solution was centrifuged and the amount of DOX released in the supernatant was determined 
by comparing its absorbance at 485 nm with the calibration curves of DOX using UV-Vis 
spectrometer. After each time points, the remained solid was re-disperseded in fresh buffer 
solution with the addition of 5 µl of 20 mg/ml Proteinase K (1~2 seconds of sonication were 
employed for better dipersion). Leakage test were performed in HEPES buffer (pH = 7), PBS 
buffer (pH = 7) and acetate buffer (pH = 5). All measurements were conducted in triplicate. 
 94 
4.4.6 Laser treatment of spheres or DOX-loaded spheres 
To the as-synthesized spheres or DOX-loaded spheres solution, laser irradiation at 805 nm was 
applied. Tests with different powers and irradiation time were performed. 
4.4.7 Determination of loading efficiency 
See Scheme 4, where m0 is the initial amount of DOX added, m1, m2, and m3 are the amount of 
DOX washed away after centrifugation.  
 
 
 
Scheme 4. Scheme demonstrating the determination of loading efficiency. 
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5.0  SUMMARY  
The work presented in this thesis focused on assembling and controlling the morphologies, 
metrics, and properties of gold nanoparticle superstructures and studying their applications. I 
demonstrated that modifications to the peptide sequences and careful control over the reaction 
conditions can affect the final structure of nanoparticle assemblies.  
In Chapter 2, I showed that the inter-fiber interaction was enhanced by modifying the C-
terminus of C12-PEPAu with additional hydrophobic phenylalanine residues, leading to fiber 
bundling and in turn the formation of thick or intertwined 1-D nanoparticle superstructures. This 
is an example of how modifications to the C-terminus of peptide conjugates can be utilized as 
another way to affect the structure of nanoparticle superstructures and their co-assembly into 
larger-scale structures.  
In Chapter 3, I emphasized the significance of controlling reaction conditions in order to 
control the diameters of hollow spherical gold nanoparticle superstructures. By using a single 
peptide conjugate, C6-AA-PEPAu, hollow spherical gold nanoparticle superstructures with varied 
diameters (~40 nm, ~75 nm, and ~150 nm) and SPR responses were prepared. Medium (~75 nm) 
and large (~150 nm) spheres exhibit broad SPR extinction in the NIR window (650-900 nm). By 
coupling the experiment and theoretical simulation, I concluded that the large SPR red-shifting 
of the medium and large spheres might be due to their possible quasi-continuous shell structure 
with defects such as pinholes.   
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In Chapter 4, I utilized these spherical nanoparticle superstructures as drug carriers and 
studied their size-dependent enzymatic stability and laser-induced drug release properties, which 
was the first demonstrated application of these spherical nanoparticle superstructures. I found 
that large spheres can be deconstructed by enzymatic degradation and laser irradiation while the 
disassembly of medium spheres can only occur under laser irradiation. I also showed that NIR 
irradiation induces drug-release from both medium and large spheres, which points toward their 
potential as materials for biomedicine related applications. 
Grouped with previous work in Rosi Group, I have demonstrated the use of peptide-based 
approaches for the synthesis and assembly of complex nanoparticle-based superstructures with 
controlled morphologies, compositions, metrics, and properties. Modifications to the molecular 
structure of peptide conjugates and control over the reaction conditions have been introduced as 
two major ways to affect the final structure and properties of the nanoparticle assemblies, which 
can be further explored in the future. For example, modifications to the N- or C-terminus of 
peptide sequences with different numbers of hydrophobic (e.g., phenylalanine) or hydrophilic 
(e.g., glutamic acid) amino acids will significantly affect the assembling ability of peptide 
conjugates. More importantly, the organic tail can be tuned to bring new assembly morphologies 
and properties. Segments responsive to external stimuli can be coupled with peptide conjugates 
to potentially prepare ‘dynamic’ structures. Other biomolecules such as DNA strands and 
biotinylated molecules can be attached to the peptide sequences to endow the bioconjugates with 
new properties. As for tuning the reaction conditions, various buffer ingredients (HEPES buffer, 
citrate buffer, TEAA buffer, Tris buffer, PBS buffer, etc.), solvent (aqueous buffer, THF, DMF, 
mixed solvents, etc.) and other factors (pH, temperature, light, magnetic field, etc.) can be 
explored.  
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Figure 46.The reverse-phase HPLC charts for the purification of peptide conjugates 1 (a), 2 (b), 3 (c), 4 (d) 
and 5 (e). 
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Figure 47. MALDI-TOF mass spectrum of purified peptide conjugates 1, 2, 3, 4 and 5 (m/z): (a) 1, 1277.8 
(M + Na), 1293.7 (M + K); (b) 2, 1424.8 (M + Na), 1440.8 (M + K); (c) 3, 1571.2 (M + Na), 1587.2 (M + K); (d) 4, 
1719.3 (M + Na), 1735.2 (M + K); (e) 5, 1553.5 (M + Na), 1569.5 (M + K). 
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Figure 48. The reverse-phase HPLC chart for the coupling reaction of AAAYSSGAPPMPPF with caproic N-
hydroxyl-succinimide ester (retention time = 16.5 min). 
 
 
 
Figure 49. MALDI-TOF mass spectrum of purified C6-AA-PEPAu (m/z): 1485.0 (M + Na), 1501.6 (M + K). 
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